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Abstract 
The gastrointestinal (GI) epithelium is a wide array of cell lineages that 
form a dynamic barrier to the external environment that regulates nutrient absorption, immunity and a 
physical barrier against organisms entering the intestinal lamina propria. However, the specific proteins 
expressed by epithelia to maintain GI function during homeostasis and inflammation and to promote 
tissue repair following injury are incompletely understood. This body of work demonstrates that one 
member of the Leucine rich repeat Ig domain containing nogo interacting protein family (LINGO) called 
LINGO3 serves a critical and previously unappreciated role in maintaining the intestinal barrier under 
homeostasis and in promoting tissue regeneration following acute tissue injury in the GI tract. Under 
steady-state conditions in co-housed animals, Lingo3 gene deficient (Lingo3 KO) mice have a marked 
dysregulation in the architecture of the adherens junction complex between small and large intestinal 
epithelial cells, which correlated with increased intestinal permeability and serum endotoxin levels. This 
mucosal barrier defect was also associated with a significant increase in Type 1 cytokines and pro-
inflammatory myeloid lineage antigen presenting cells. Interestingly, Lingo3 deficiency did not confer 
resistance or susceptibility to the enteropathogenic bacterium Citrobacter rodentium. However, when 
Lingo3 KO mice were exposed to the dextran sodium sulfate (DSS) model of colitis, they developed 
significantly worse disease than co-housed wild-type (WT) controls as defined by overall morbidity, 
clinical score, reduced colon length, and histological changes, particularly during the recovery phase of 
DSS. Curiously, this basal defect and DSS recovery phase defect was remarkably similar to the phenotype 
of mice genetically deficient in Trefoil factor 2 (Tff2), a goblet cell-derived cytokine known to promote 
tissue repair. This dissertation also demonstrates that treatment of DSS-treated WT mice with a long-
acting agonist of TFF2 (TFF2-Fc) promotes faster tissue recovery than Lingo3 KO mice. This enhanced 
tissue recovery mediated by TFF2-Fc was associated with a greater number of intestinal epithelial cells 
showing phosphorylation of ERK, which is a key transcription factor in the MAPK pathway that promotes 
cellular proliferation. To directly test whether LINGO3 and TFF2 functioned to drive epithelial cell 
regeneration distinct from their impact upon inflammation, we generated small and large intestinal 
organoids. Results show that both Lingo3 deficient and Tff2 deficient organoids had defective growth 
kinetics and impaired architectural structure. Strikingly, both Lingo3 deficient and Tff2 deficient small 
intestinal organoids had decreased mRNA transcript levels of the intestinal stem cell marker, Lgr5, 
implying that defects in stem cell abundance and/or function. In conclusion, the body of work comprising 
this dissertation demonstrates that LINGO3 serves a previously unappreciated role in mucosal epithelial 
cell barrier function under homeostasis and during tissue repair following colitic injury. This role partially 
functions through the reparative cytokine TFF2, which collectively warrants further investigation into how 
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ABSTRACT 
LEUCINE RICH REPEAT IG-DOMAIN CONTAINING NOGO INTERACTING 
PROTEIN 3 (LINGO3) IS A NOVEL REGULATOR OF MUCOSAL HOMEOSTASIS 
AND 
TISSUE REPAIR IN THE GASTROINTESTINAL TRACT 
Kelly M. Zullo 
De’Broski R. Herbert 
 The gastrointestinal (GI) epithelium is a wide array of cell lineages that  
form a dynamic barrier to the external environment that regulates nutrient absorption,  
immunity and a physical barrier against organisms entering the intestinal lamina propria. 
However, the specific proteins expressed by epithelia to maintain GI function during 
homeostasis and inflammation and to promote tissue repair following injury are 
incompletely understood. This body of work demonstrates that one member of the Leucine 
rich repeat Ig domain containing nogo interacting protein family (LINGO) called LINGO3 
serves a critical and previously unappreciated role in maintaining the intestinal barrier 
under homeostasis and in promoting tissue regeneration following acute tissue injury in the 
GI tract. Under steady-state conditions in co-housed animals,  Lingo3 gene deficient 
(Lingo3 KO) mice have a marked dysregulation in the architecture of the adherens junction 
complex between small and large intestinal epithelial cells, which correlated with increased 
intestinal permeability and serum endotoxin levels. This mucosal barrier defect was also 
associated with a significant increase in Type 1 cytokines and pro-inflammatory myeloid 
lineage antigen presenting cells. Interestingly, Lingo3 deficiency did not confer resistance 
or susceptibility to the enteropathogenic bacterium Citrobacter rodentium. However, when 
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Lingo3 KO mice were exposed to the dextran sodium sulfate (DSS) model of colitis, they 
developed significantly worse disease than co-housed wild-type (WT) controls as defined 
by overall morbidity, clinical score, reduced colon length, and histological changes, 
particularly during the recovery phase of DSS. Curiously, this basal defect and DSS 
recovery phase defect was remarkably similar to the phenotype of mice genetically 
deficient in Trefoil factor 2 (Tff2), a goblet cell-derived cytokine known to promote tissue 
repair. This dissertation also demonstrates that treatment of DSS-treated WT mice with a 
long-acting agonist of TFF2 (TFF2-Fc) promotes faster tissue recovery than Lingo3 KO 
mice.  This enhanced tissue recovery mediated by TFF2-Fc was associated with a greater 
number of intestinal epithelial cells showing phosphorylation of ERK, which is a key 
transcription factor in the MAPK pathway that promotes cellular proliferation. To directly 
test whether LINGO3 and TFF2 functioned to drive epithelial cell regeneration distinct 
from their impact upon inflammation, we generated small and large intestinal organoids. 
Results show that both Lingo3 deficient and Tff2 deficient organoids had defective growth 
kinetics and impaired architectural structure. Strikingly, both Lingo3 deficient and Tff2 
deficient small intestinal organoids had decreased mRNA transcript levels of the intestinal 
stem cell marker, Lgr5, implying that defects in stem cell abundance and/or function. In 
conclusion, the body of work comprising this dissertation demonstrates that LINGO3 
serves a previously unappreciated role in mucosal epithelial cell barrier function under 
homeostasis and during tissue repair following colitic injury. This role partially functions 
through the reparative cytokine TFF2, which collectively warrants further investigation 
into how this putative TFF2-LINGO3 axis regulates enterocyte and intestinal stem cell 
function during health and disease.   
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Chapter 1: Introduction 
1.1 The composition of the gastrointestinal mucosal barrier 
 The gastrointestinal (GI) tract is a complex organ whose predominant function is 
to absorb nutrients. It is also the largest mucosal barrier surface within the body and must 
regulate exposure to both commensal and pathogenic organisms (Kiela and Ghishan, 2016; 
Oshima and Miwa, 2016; Vancamelbeke and Vermeire, 2017). Because of the multi-
functional role of the GI tract, it is composed of a diverse subset of cells, molecules, and 
proteins that are necessary to maintain homeostasis (Wiles et al., 2004). 
 Commensal bacteria live in the lumen of the barrier in symbiosis with the host. 
These bacteria are comprised of 4 dominant phyla; Firmicutes, Bacteroidetes, 
Actinobacteria, and Proteobacteria (Tlaskalova-Hogenova et al., 2011). Although it is well 
accepted that these commensal bacteria are present within the GI tract, the exact role of 
each microbial phyla is not well understood. However, it is known that the mammalian 
host can derive factors from commensals, which allows for the maintenance of the mucosal 
layer as well as influence homeostasis within the GI tract (Lee et al., 2013; Martin-
Gallausiaux et al., 2018; Ohue et al., 2011). When this microbial diversity is disrupted, it 
can lead to inflammatory disorders such as Crohn’s disease, Ulcerative colitis, or 
outgrowth of pathogenic bacteria like Escherichia coli (E. coli) (Hiippala et al., 2018; Yu, 
2018). 
 Along with commensal bacteria, a mucus biogel covers the barrier and acts as a 
protective layer to prevent any bacteria or pathogens from entering into the lamina propria. 
This mucus is a thick layer of viscous fluid comprised of secreted factors such as mucins, 
antimicrobial peptides (AMP), and immunoglobins (Ig) that control and sense 
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macromolecules and pathogens from coming in contact with the epithelium. Mucins 
(MUC) are a family of large glycosylated proteins secreted from epithelial cells that 
prevents microorganisms from easily invading the deeper tissues of the GI tract. To date, 
there are 20 known mucins, each mucin has a functional role in killing bacteria, however, 
some mucins such as MUC5B has been shown to maintain bacteria within the oral 
microbiome (Cardenas et al., 2007; Corfield, 2015; Frenkel and Ribbeck, 2015; Wickstrom 
et al., 2009). Additionally, some strains of mucin deficient mice such as Mucin2 (Muc2) 
have an increase in colonic invasion, further demonstrating the functional role of mucins 
in forming a protective layer at the mucosal interface with the external environment 
(Johansson et al., 2008). 
 In addition to mucins, the GI mucus layer contains anti-microbial peptides (AMPs). 
AMPs are an evolutionary conserved family of proteins comprised of defensins, 
cathelicidins, and regenerating islet derived protein 3 (REGIII) proteins (Cash et al., 2006; 
Pound et al., 2015; Salzman et al., 2003; Sass et al., 2010; Vaishnava et al., 2011; Wilson 
et al., 1999; Yi et al., 2017). These proteins interact with bacterial cell membranes, form 
pores, and lead to the membrane disruption, and subsequent killing of bacteria (Cash et al., 
2006; Vaishnava et al., 2011). Work from Lora Hooper's group first identified REGIIIg, a 
lectin binding protein, secreted by Paneth cells that preferentially binds to peptidoglycans 
of Gram-positive bacteria leading to a decrease in bacterial viability (Cash et al., 2006; 
Vaishnava et al., 2011). While AMPs are important for homeostasis within the mucosa, 
other proteins such as immunoglobulin A (IgA) can be secreted into the mucosa and entrap 
receptor-binding domains of dietary antigens in mucus (Apter et al., 1993; Forbes et al., 
2008; Mantis et al., 2006; Silvey et al., 2001). 
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 This maintains microbial communities within the barrier, and sterically hinders 
microbes from binding within the epithelium (Apter et al., 1993; Forbes et al., 2008; Mantis 
et al., 2006; Silvey et al., 2001). Furthermore, upon receptor-binding, IgA can induce 
antibody dependent cellular cytotoxicity (Black et al., 1996; Tagliabue et al., 1984; 
Tagliabue et al., 1983). While mucins, AMPs, and IgA are essential for maintaining 
commensal and pathogenic bacteria from interacting with the epithelium, the cells that 
secrete these proteins are important for a better understanding of the signaling pathways 
required during homeostasis and injury. 
Epithelial subtypes that comprise the gastrointestinal tract 
 The GI epithelium renews every three to five days (Krndija et al., 2019). Within 
the GI tract there are different subsets of epithelial cells that comprise the small intestine 
and colon. The three main subsets of epithelial cells that comprise the barrier are 
enterocytes, goblet cells, and intestinal stem cells which function as the second layer of 
separation from the gut microbiota and host immune cells (Fig 1.1) (Barker et al., 2007; 
Jit, 1953; Lauber et al., 1989; Moe, 1953; Reunanen et al., 2015; Specian and Neutra, 
1980). Enterocytes are polarized cells that line the apical surface of the intestinal tract and 
form the cellular polarity required for barrier integrity and transportation of 
macromolecules across the epithelium (Massey-Harroche, 2000). Interestingly, as 
enterocytes mature, they become more polarized such that enterocytes at the villus tip have 
the highest membrane potential (Tsuchiya and Okada, 1982). The barrier integrity is further 
reinforced by the apical junction complex (AJC). This complex of proteins is found 
between enterocytes and forms tight junctions and adherens junction, the physical barrier 
of the epithelium which prevents “leaky” areas. Key proteins of the AJC include: claudins, 
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occludens, zonula occludens, cadherins, nectins, and integrins (Capaldo et al., 2014; 
Coopman and Djiane, 2016; Duraivelan et al., 2018; Itoh et al., 1999; Kruse et al., 2019; 
Rajasekaran et al., 2008) . Deficiency in any of these protein classes can result in pathogens 
entering into the lamina propria and propagating inflammation and initiating an immune 
response (Capaldo et al., 2014; Ulluwishewa et al., 2011). Besides cellular polarity, 
enterocytes have microvilli on their surface which prevents pathogens, bacteria, and/or 
particles from direct contact with the barrier. Additionally, these microvilli aid in digestion 
of macromolecules. Furthermore, enterocytes can process luminal antigens and present 
antigen to immune cells like CD8+ and CD4+ T cells, through the expression of major 
histocompatibility complex (MHC) I and II proteins, respectively (Hershberg and Mayer, 
2000). 
 Goblet cells are the mucus producing cells of the GI tract. Goblet cells can secrete 
mucins, proteins, and trefoil factors, small proteins that promote intestinal repair, 
migration, and restitution in response to external stimuli (McCauley and Guasch, 2015). 
These cells are essential for maintaining the mucus layer and preventing bacteria from 
interacting with the epithelium. In fact, germ-free mice have less goblet cells, reducing the 
amount of mucus found within the GI tract because of the lack of commensals (Kjetland et 
al., 2014). In addition to goblet cells, there are other secretory epithelial cells within the 
barrier known as Paneth cells. Paneth cells are secretory cells found within the small 
intestine that produce AMPs while the colon contains Paneth like cells. These cells secrete 
AMPs and lysozymes which can aid in the killing of bacteria. Additionally, Paneth cells 
are known to be a specialized cell within the stem cell niche and serve a role in tissue 
regeneration (Schmitt et al., 2018). 
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 Lastly, intestinal stem cells (ISC) are found at the base of the crypt. The 
composition of the stem cell niche is complex and diverse including four different types of 
stem or stem-cell like cells including the Lgr5+ stem cell, +4 quiescent cells, transit 
amplifying cells, and Paneth cells (Lauber et al., 1989). The stem cell niche is not only 
necessary during continual renewal of the epithelium during homeostasis, but also plays a 
critical role during injury and intestinal inflammation. The base of the crypt is where Lgr5+ 
stem cells are found. This has been shown to be the main stem cell found within the 
intestinal crypts. Lgr5 is a G-protein coupled receptor with a leucine rich extracellular 
domain that is a target gene of Wnts (Baker et al., 1991). Work from Hans Clever's 
laboratory has demonstrated that Lgr5 gene expression is diminished when Wnt signaling 
is inhibited. Furthermore, Lgr5 was expressed on cycling crypt columnar cells found 
between Paneth cells, further suggesting that the Lgr5+ cell and Paneth cells were distinct 
from each lineages (Baker et al., 1991). There are approximately three Lgr5+ cells per small 
intestinal crypt while the colonic crypts have approximately six to eight (Baker et al., 1991; 
Bjerknes and Cheng, 1999; Kozar et al., 2013; Ritsma et al., 2014; Snippert et al., 2010). 
These Lgr5+ cells express high levels of Ki-67, a marker of proliferation, and self-renew 
every twenty-four hours following depletion leading to the renewal of enterocytes, goblet 
cells, and Paneth cells (Baker et al., 1991). Paneth cells or Paneth-like cells are found 
adjacent to the Lgr5+ cells within the small intestine and colon, respectively. In addition to 
secreting lysozymes and AMPs, Paneth cells also provide support to Lgr5+ cells through 
cell-cell contact and secretion of epidermal growth factor (EGF), Wnt3a, and notch ligand 
Delta-like 4 (DLL4), proteins that are necessary for LGR5 maintenance (Schmitt et al., 
2018). 
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 There are +4 quiescent cells found adjacent to the Paneth cells. +4 quiescent cells 
were first identified at the +4 position of the stem cell niche and shown to retain DNA 
label, suggestive of a slow cycling cell (Marshman et al., 2002; Potten et al., 1974). It is 
estimated there are four to six +4 quiescent cells per crypt. These cells can self-renew and 
give rise to all differentiated cell lineages. Although +4 cells have been shown to self- 
renew, the gene markers used to identify these cells are not unique to this specific stem cell 
lineage. To date proto-oncogene, polycomb ring finger (BMI1), telomerase reverse 
transcriptase (TERT), homeodomain-only protein homeobox (HOPX), and leucine rich 
repeats and immunoglobulin like domain 1 (LRIG1) are the main gene markers used to 
identify these cells (Schmitt et al., 2018). Transit amplifying (TA) cells are found above 
+4 quiescent cells. These cells are typically located at the crypt-villus junction and give 
rise to enterocytes, goblet cells, and enteroendocrine cells. Each subset of epithelial cells 
that form the stem cell niche are necessary for response during inflammation and injury, 
however, exactly how each of these cell subsets are regulated and which subsets can form 
compensatory mechanisms when one or more populations are diminished is not well 
understood. 
1.2 The immunobiology of regulating the mucosal barrier  
Regulation of the intestinal stem cell niche 
 Work from the Clevers lab has demonstrated that Wnt signaling within the stem 
cell niche is necessary for maintenance of Lgr5+ cells and crypt proliferation (Sato et al., 
2009). R-spondin 1 is a WNT ligand that binds to LGR5 and induces crypt hyperplasia. 
Following binding to LGR5, WNTs simultaneously bind to LRP5/6 and frizzled, a Wnt 
ligand, leading to the phosphorylation of LRP5/6 by CK1 and GSK3 (de Lau et al., 2011; 
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Kim et al., 2008; Moparthi and Koch, 2019). Phosphorylation of LRP5/6 leads to the 
recruitment of the disheveled complex to the plasma membrane which interacts with 
Frizzled, other disheveled polymers, and Axin, leading to the destruction of the disheveled 
complex and translocation of b-catenin to the nucleus (Carmon et al., 2012; Moparthi and 
Koch, 2019). Within the nucleus, b -catenin binds to Lymphoid enhancer- binding factor/T-
cell factor (LEF/TCF) complex and turns on transcription of Wnt responsive genes 
(Carmon et al., 2012; Moparthi and Koch, 2019). The Wnt signaling pathway is crucial for 
intestinal stem cell growth and differentiation (de Lau et al., 2011). However, a balance is 
required to maintain homeostasis, therefore, to inactivate WNT signaling, ZNRF43, a stem 
cell enriched gene with a protease associated domain, binds to 
LRP5/6 preventing the phosphorylation of LRP5/6 and the degradation of the Frizzled/LRP 
receptors (Moparthi and Koch, 2019). The outcome of this prevents undesired stem cell 
growth and differentiation; therefore, maintaining the number of stem cells and 
differentiated cells within the stem cell niche at all times. 
 In addition to WNT signaling, epidermal growth factor (EGF), Notch, and noggin 
signaling are necessary for intestinal proliferation and expansion of crypt numbers, 
respectively (Sato et al., 2009). As the Lgr5+ cell self-renews, daughter cells migrate up 
the villus over 5 days, and differentiate into nutrient absorbing enterocytes and secretory 
cells such as goblet cells producing mucins or hormones (Koo and Clevers, 2014; Sato et 
al., 2009). At the tip of the villus these differentiated epithelial cells undergo apoptosis 
allowing for space within the intestinal crypt for newly differentiated epithelial cells to 
migrate throughout the villus. As the stem cell niche renews and differentiates, enterocytes 
form the AJC to reinforce and polarize the barrier integrity. 
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Regulation of the apical junction complex 
 At the tip of the villus, enterocytes express adhesion molecules that form the AJC. 
As previously mentioned, this complex is composed of the tight junctions, located at the 
apical side of the lumen, while the adherens junction are located closer to the basolateral 
side of the membrane. The formation of this complex is necessary to prevent any pathogens 
from entering into the lamina propria. Although the exact receptors and proteins that 
promote the formation of the AJC are not known, the proteins required for the formation 
of this structural complex are known. 
 The AJC consists of tight junctions, adherens junction, gap junctions, and 
desmosomes. The tight junctions are comprised of a variety of transmembrane proteins 
including claudins, occludens, and zonula occludens (ZO) (Fig 1.2) (Farquhar and Palade, 
1963; Itoh et al., 1999). This complex can interact with the actin cytoskeleton and regulate 
the transportation of nutrients, ions, and water molecules across the barrier (Payne et al., 
2006; Ulluwishewa et al., 2011; Van Itallie et al., 2015). Occludens and claudins can both 
bind the ZO forming a tricellular protein complex (Gauberg et al., 2019; Raleigh et al., 
2011). Claudins are the structural backbone of the tight junction. 
Claudins 1, 3, 4, 5, and 8 decrease paracellular permeability while claudin 2 can form 
charge selective paracellular pores (Amasheh et al., 2002; Angelow et al., 2006; Cong et 
al., 2015; Furuse et al., 2002; Piontek et al., 2008). Occludens regulate the diffusion of 
small molecules such that if occludens are deleted from cells there is an increase in 
paracellular flux and permeability, however transepithelial resistance is unaffected (Al- 
Sadi et al., 2011; Balda et al., 1996). Zonula occludens are plaque proteins identified by 
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PSD95-DlgA-ZO-1 homology (PDZ) domains. ZO proteins contain three PDZ domains 
which allows ZO-1 to interact with claudins, other ZO proteins to form dimers, and 
interaction with junctional adhesion molecule A (JAM-A), respectively (Ulluwishewa et 
al., 2011). Interestingly, plaque proteins can also function to reorganize the cytoskeleton 
through binding directly to F-actin (Ulluwishewa et al., 2011). Junctional adhesion 
molecules (JAMs) are transmembrane proteins found below the tight junctions. These 
proteins are necessary for the assembly of the tight junction (Liu et al., 2000) and have also 
been shown to bind effectors of the Rho-family of small GTPases (Mandell et al., 2005; 
Severson et al., 2009). 
 Rho family of GTPases, protein kinase c (PKC), mitogen activated protein kinase 
(MAPK), and myosin light chain kinase (MLCK) are the four main signaling proteins 
known to regulate tight junctions, interactions between AJC proteins, and the actin- myosin 
ring (Basuroy et al., 2006; Farhadi et al., 2006; Turner et al., 1997). RHO kinases can 
phosphorylate the myosin II regulatory light chain inducing contraction of the actin- 
myosin ring (Kimura et al., 1996; Nusrat et al., 1995; Shen et al., 2006). Furthermore, 
Walsh et al. demonstrated that inhibition of RHO kinases prevents localization of tight 
junction proteins in cultured T84 human colonic epithelial cell monolayers, supporting the 
hypothesis that RHO kinases are sufficient for tight junction localizations and assembly 
(Walsh et al., 2001). Intestinal epithelial cells express multiple isoforms of PKC which can 
redistribute ZO-1 and increase transepithelial electrical resistance (TEER), a measure of 
paracellular ion permeability. Furthermore, epidermal growth factor (EGF) secreted from 
intestinal stem cells can activate MAPK and prevent tight junction disruption from 
chemical induced injury caused by hydrogen peroxide (Basuroy et al., 2006). In addition, 
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extracellular signal kinase (ERK) can interact directly with occludens to prevent chemical 
disruption of tight junctions (Basuroy et al., 2006). Following the formation of the tight 
junction complex, commensals can also increase the expression of ZO proteins, however 
the exact mechanism of how commensals or metabolites from commensals promotes 
induction of ZO proteins is not known (Madsen et al., 2001). 
 Below tight junctions and JAMs are the adherens junction (Fig 1.2). The adherens 
junction is comprised of cadherins and nectins, two transmembrane adhesive receptors. 
Epithelial cadherin (E-cadherin) is expressed by epithelial cells and contains five 
immunoglobin like extracellular cadherin repeat domains (Coopman and Djiane, 2016; 
Tunggal et al., 2005). These domains can form cis and trans dimers with cadherins on the 
same cell and with adjacent cells, respectively (Shapiro and Weis, 2009; Wu et al., 2010). 
The cytoplasmic tail of E-cadherin interacts with catenin proteins, mainly b-catenin, 
preventing b-catenin from entering into the nucleus and binding Lef, which initiates 
transcription. Upon binding of E-cadherin to b-catenin, b-catenin binds a-catenin linking 
E-cadherin to the actin cytoskeleton (Aberle et al., 1994). Additionally, E-cadherin also 
binds to integrins such as integrin alpha e also known as CD103 (Van den Bossche et al., 
2012). Because CD103 is an integrin that is expressed by a variety of cells including 
epithelial cells as well as immune cell subsets this binding can allow for cell specific 
interaction to the adherens junctions (Van den Bossche et al., 2012). 
 Nectins are single pass transmembrane proteins with three Ig-like loops that allow 
for dimerization of nectins and promotion of cell-cell adhesion as well as apical- basolateral 
polarity (Takahashi et al., 1999; Takai and Nakanishi, 2003). The cytoplasmic tail of 
nectins contain a PDZ domain that binds afadin, the actin binding protein necessary for 
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anchoring nectins to the actin cytoskeleton (Takahashi et al., 1999; Takai and Nakanishi, 
2003) This anchoring allows adherens junction to mature and readily localizes cadherin to 
cell-cell junctions (Fig 1.2) (Campbell et al., 2017). In the absence of E-cadherin, tight 
junctions as well as desmosomes do not properly form, suggesting the essential role of this 
protein in barrier formation (Tunggal et al., 2005). Additionally, E-cadherin deficient mice 
have worsened colitis following administration with dextran sodium sulfate (DSS), a 
chemical that is water soluble, negatively charged sulfated polysaccharide which is 
administered in drinking water (Grill et al., 2015; Judd et al., 2015; Kurt-Jones et al., 2007). 
Furthermore, polymorphisms within E-cadherin are associated with Crohn’s disease 
(Muise et al., 2009). This intricate formation of the AJC forms a barrier within the GI 
epithelium preventing commensal or pathogenic bacteria from translocating into the lamina 
propria. However, if there is a barrier breach, either injury induced or chemically induced, 
the lamina propria is full of immune cell subsets readily available to launch an immune 
response. 
Immune cell subsets of the gastrointestinal tract 
 Within the lamina propria there are two main antigen presenting cells (APC), 
dendritic cells (DC) and macrophages, both of which can present antigens to T cells and 
elicit an immune response (Fig 1.3). Importantly, there are more than just one subset of 
these cells, specifically, dendritic cells can be conventional DC 1 (cDC1) identified by the 
chemokine receptor X-C motif 1 (XCR1), conventional dendritic cell 2 (cDC2) identified 
by the signal regulatory protein-a (SIRPa), as well as plasmacytoid dendritic cells (pDC) 
(Cella et al., 1999; Piqueras et al., 2006; Schiavi et al., 2015). Within the small intestine 
and large intestine there are different abundancies of these DC subtypes, however, the 
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function of the DCs remains the same across each tissue. cDC1 can be characterized by the 
surface markers CD11c+ MHCII+ XCR1+, however these cells can also either be CD103+ 
or CD103-. The expression of CD103 allows these DCs to transmigrate through the barrier 
and sample antigen within the lumen as well as interact and bind to E-cadherin on IECs 
(Schulz et al., 2009). Additionally, the CD103+ DCs have also been shown to migrate to 
the lymph node and activate T cells (Schulz et al., 2009)). This interaction has been shown 
to maintain T lymphocytes within the mucosa (Schon et al., 1999). T lymphocytes can 
become polarized towards a Type 1 immune response (TH1), Type 2 immune response 
(TH2), and towards anti-inflammatory responses such as those elicited from T-regulatory 
(Treg) cells (Shale et al., 2013). CD103 deficient mice not only have reduced numbers of 
T lymphocytes within the mucosa, but in addition have reduced retention of Tregs within 
wounds (Suffia et al., 2005). Importantly, cDC cells can migrate to the draining lymph 
node of the GI tract, the mesenteric lymph node (MLN) and re-enter into the GI tract, 
allowing these cells to elicit immune responses in both locations. 
 The other major APC within the GI tract are macrophages, which can be divided 
into two subtypes; macrophage 1 (M1) or macrophage 2 (M2). M1 macrophages are 
typically associated with Type 1 immune responses while M2 macrophages are associated 
with wound healing and Type 2 immune responses (Mills et al., 2000; Nathan et al., 1983; 
Stein et al., 1992). Similar to DCs, within the mucosa, macrophages can be transepithelial 
and sample antigen within the lumen of the GI tract through expression of CX3CR1 (Niess 
et al., 2005). In contract to DCs, macrophages are poor in activating naïve T lymphocytes 
and thus present antigen to previously activated T cells (Schulz et al., 2009). 
 Following antigen presentation, naïve CD4+ T cells can become activated to elicit 
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an immune response. Within the lamina propria there are Type 17 (TH17), Type 1 (TH1), 
Type 22 (TH22), Type 2(TH2), and Type 9 (TH9) CD4+ T cells (Fig 1.3) (Kara et al., 
2014). Each subset secretes different sets of cytokines that drive pro- and anti- 
inflammatory responses as well as regulate the activation of APCs. Importantly, T cells can 
migrate from the lamina propria into the MLN and back, a process that is augmented when 
there is a barrier breach (Kara et al., 2014). In the next chapter, we will further discuss the 
cytokines that these cells secrete and how these cells respond to different barrier breaches. 
In addition to CD4+ T cells, CD8+ T cells are also present in the intestine. In contrast to 
CD4+ T cells providing T cell help, CD8+ T cells are cytolytic (Jiang et al., 2003; Lykens 
et al., 2011; Mouchacca et al., 2015; Salti et al., 2011; Yang et al., 2019b). CD8 T cells can 
secrete perforin as well as granzyme B promoting clearance of bacteria, pathogens, and 
viruses (Jiang et al., 2003; Lykens et al., 2011; Mouchacca et al., 2015; Salti et al., 2011; 
Yang et al., 2019b). 
 Furthermore, innate lymphoid cells (ILCs), are a subset of cells first identified in 
the early 2000s to be present within the barrier surfaces such as the GI mucosa (Fig 1.3). 
There are three subsets (ILC1, ILC2, ILC3) which are characteristically distinct from T- 
helper cells because they do not express recombinant T cell receptors but are functionally 
very similar to TH1, TH2, or TH17 cells, respectively (Artis and Spits, 2015). Innate 
lymphoid cells also do not express B or myeloid cell markers, thus are lineage negative, 
however they do express the IL-2 (CD25) receptor and the IL-7 (CD127) receptor (Artis 
and Spits, 2015). Within the GI mucosa, ILC1 cells are abundant in the upper GI tract while 
ILC3 and lymphoid tissue inducer (LTi) cells, a subset of ILC3, are found in abundance 
within the colon, and ILC2 cells are expressed in very low amounts in the entire GI tract 
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(Kramer et al., 2017). ILC1 have been shown to be important in immunity against 
intracellular bacteria while ILC3 and LTi have been shown to be important in immunity 
against extracellular bacteria (Geremia et al., 2011; Hanash et al., 2012; Kirchberger et al., 
2013; Sonnenberg et al., 2011). Interestingly, both subsets have been shown to have roles 
in the induction of inflammatory responses that drive colitis (Geremia et al., 2011; Hanash 
et al., 2012; Kirchberger et al., 2013; Sonnenberg et al., 2011). ILC1 cells also include 
natural killer (NK) cells. NK cells have cytolytic activity and can secrete enzymes that are 
pore forming (perforin 1) to mediate apoptosis in a cell- specific manner (Chattopadhyay 
et al., 2009). 
 All of these different immune cell subsets work in conjunction with one another to 
elicit immune responses when there is a barrier breach within the mucosa. Each cell type 
can secrete a variety of cytokines and enzymes to lead to inflammation, cell death, or limit 
inflammation through anti-inflammatory responses. The balance of these elicited immune 
responses limits gross pathology, ulcers, bacterial outgrowth, colitis, as well as cancer. 
1.3 Regulation of the mucosal barrier  
Type 1 immune responses 
 Following a barrier breach, a number of immune responses are elicited to limit 
pathology and damage to the mucosa. Upon injury, the first line of defense, are the IECs. 
Intestinal epithelial cells can secrete interleukin 18 (IL-18), interleukin 1b (IL-1 b), as well 
as TNF to drive a TH1 immune response (Nowarski et al., 2015; Roulis et al., 2011; 
Waterhouse and Stadnyk, 1999). Secretion of IL-18 can promote TH17 cellular 
differentiation as well as increase Treg effector function (Harrison et al., 2015). 
Furthermore, the secretion of IL-18 can induce macrophages to produce interferon gamma 
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(IFNg) as well as promote OX40 ligand (OX40L) expression on DCs. The expression of 
OX40L on DCs allow for binding to OX40, the receptor of OX40L, that is expressed on T 
cells and promote T-cell survival (Maxwell et al., 2006; Szpakowski et al., 2015). Upon 
activation, DCs can secrete pro-inflammatory cytokines such as interleukin-12/23p40 (IL-
12/23p40) which in turn promotes TH1 cells to become activated and secrete IFNg and 
TNF (Reinhardt et al., 2006). Secretion of IFNg acts in a positive feedback loop, because 
IFNg can activate macrophages to produce IL-12/23p40, leading to a persistent 
inflammatory immune response (Cohen et al., 2015). To counteract this immune response 
and limit inflammation, the anti-inflammatory cytokine interleukin-10 (IL-10) is secreted 
by macrophages and T-reg cells. The secretion of IL-10 is crucial for limiting inflammation 
and tissue injury (Rubtsov et al., 2008). 
  Other than TH1 cells, TH17 cells and TH22 cells are also necessary for intestinal 
inflammatory control. These cells secrete interleukin 22 (IL-22) as well interleukin-17A 
(IL17A) that can promote chemokines to attract immune specific cell subsets to the site of 
injury, as well as promote AMPs, respectively. Interleukin-22 can be secreted from TH17, 
TH22, ILC3, and LTi cells. Importantly, IL-22 can also induce expression of REGIIIg and 
REGIIIb from intestinal epithelial cells causing bacteria cell death (Bachmann et al., 2010; 
Zindl et al., 2013). Furthermore, IL-22 has been implicated in wound repair through 
promotion of intestinal stem cell mediated epithelial regeneration (Lindemans et al., 2015). 
Lindemans et al. demonstrated that IL-22 increases the growth of intestinal organoids, 
reduces intestinal pathology of graft versus host disease, and increases the recovery of 
Lgr5+ stem cells in graft versus host disease (Lindemans et al., 2015). Although Type 1 
immune responses are elicited during bacterial invasion, Type 2 immune responses are also 
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elicited during helminth infections allergen-induced epithelial damage.  
Type 2 immune responses 
 Intestinal epithelial cells can secrete thymic stromal lymphopoietin (TSLP), the 
alarmin, interleukin 33 (IL-33), as well as interleukin-25 (IL-25) (Kim et al., 2013; Saenz 
et al., 2013; Taylor et al., 2009; Xiao et al., 2019; Zeuthen et al., 2008). These cytokines 
can promote M2 polarization leading to the secretion of interleukin 4 (IL-4), interleukin 13 
(IL-13), and TGFb which in turn polarizes a TH2 cell response (Pichery et al., 2012; 
Schiering et al., 2014; Xiao et al., 2019). Furthermore, following release of IL-33 there is 
a subsequent promotion of T-regulatory cell expansion (Schiering et al., 2014). Outside of 
promoting type 2 responses, IL-33 can also improve wound healing (He et al., 2017; 
Lopetuso et al., 2018). 
Regenerative proteins in mucosa barrier homeostasis 
 In addition to cytokine secretion, there are small proteins known as Trefoil factors 
(TFFs) secreted from goblet cells that play a crucial role in epithelial repair. The Trefoil 
factor family of proteins was first identified in the 1990s and shown to be a family of three 
small (7-14kDa) proteins (TFF1, TFF2, TFF3) expressed within mucosal barriers including 
the lung and GI tract (Thim, 1989). These proteins contain a distinct domain known as the 
Trefoil domain that is 38-39 amino acid residues containing 6 cysteines linked by disulfide 
bonds to form a three-leaved structure (Thim, 1989). TFF1 and TFF3 contain only one 
domain while TFF2 contains two Trefoil domains (Thim, 1989). When first identified, 
TFF1 and TFF2 were found to be expressed in the stomach of humans while TFF3 was 
expressed within the intestinal tract, however, work published from our lab as well as 
others have demonstrated in mice TFF2 is also expressed within the GI tract (McBerry et 
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al., 2012; Podolsky et al., 1993; Suemori et al., 1991; Tomita et al., 1995; Wills-Karp et 
al., 2012). 
 TFF proteins have been implicated in functional roles promoting epithelial 
restitution or the migration of cells to the site of injury, inhibition of apoptosis, as well a 
cellular proliferation (Buda et al., 2012; Hoffmann, 2005; Playford et al., 1995). Playford 
et al. demonstrated enhanced migration of HT29 cells, a human colon carcinoma line, when 
grown on collagen gel and treated with human TFF2 (Playford et al., 1995). During 
cellular restitution, cells need to detach from their cell-cell contacts in order to migrate, 
thus a mechanism that prevents cellular apoptosis when these cells detach from their cell- 
cell contacts would to enhance restitution and potentially promote faster recovery from 
injury. Taupin et al demonstrated that following transfection with TFF3, HT-29 cells were 
resistant to serum withdrawal while vector control cells were sensitive and had 
increased apoptosis (Taupin et al., 2000). Taupin et al. further demonstrated that TFF3 can 
inhibit apoptosis in both a p53 dependent and independent manner (Taupin et al., 2000). 
 During the restitution phase of colitis, TFF3 protein levels are increased; however, 
studies are contradictory over whether or not Tff3 deficient mice are more susceptible to 
colitis (Belle et al., 2019; Kjellev et al., 2007; Mashimo et al., 1996; Podolsky et al., 2009; 
Renes et al., 2002). These data suggest that TFF3 may be sufficient, but not necessary for 
healing during colitis. Furthermore, these data demonstrate that TFF proteins are crucial 
regenerative proteins of the mucosa. While TFFs are typically secreted from goblet cells 
during injury, TFF2 has also been shown to be expressed in spleen, peritoneal cells, 
macrophages, as well as embryonic fibroblasts, suggestive that this protein has functional 
roles in immune responses elicited during inflammation and injury (Kurt-Jones et al., 2007; 
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McBerry et al., 2012). McBerry et al. demonstrated that TFF2 acts on macrophages and 
DCs to negatively regulate IL-12/23p40, such that Tff2 deficient mice have enhanced Type 
1 immune responses and immunity against Toxoplasma gondii, an obligate intracellular 
protozoan that crosses the GI epithelium and disseminates into the central nervous system 
(McBerry et al., 2012). In addition, Tff2 deficient mice mount enhanced Type 1 immune 
responses and have more severe colitis that WT controls following DSS administration 
(Judd et al., 2015; Kurt-Jones et al., 2007). Furthermore, TFF2 production can induce IL- 
33 leading to enhanced Type 2 immunity during allergic and Nippostrongylus brasiliensis 
infection (Wills-Karp et al., 2012). These data all support the role of Trefoil factors during 
injury and wound healing. Although these proteins have been studied since the early 90's 
and have been shown to have functional roles during injury and inflammatory responses, 
exactly how TFFs signal to promote these functions is not well understood. 
 To date there have been a number of putative TFF receptors (Chinery and Cox, 
1995; Chinery et al., 1993; Dubeykovskaya et al., 2009; Gajhede et al., 1993). It has been 
shown that Trefoils form a complex with mucins, allowing for resistance to proteases and 
mechanical stress, however, the exact proteins involved in this complex have not be 
identified (Gajhede et al., 1993). Because the TFF proteins function at sites of injury, it is 
postulated that potential Trefoil receptors would be within the same vicinity of the injury 
site. Importantly, cellular binding sites have been found within all TFFs, further suggesting 
a Trefoil binding partner (Chinery and Cox, 1995; Chinery et al., 1993; Poulsen et al., 2003; 
Poulsen et al., 1998). Thim et al. found using affinity chromatography on TFF2 that there 
were two potential receptors, a CRP-ductin gene expressed within intestinal crypts as well 
as a B subunit of fibronectin receptor (Thim and Mortz, 2000). However, future studies 
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were unable to prove direct binding of TFF2 to these receptors, suggestive that the two 
receptors and TFF2 were not a protein-ligand pair (Otto and Thim, 2005; Thim and Mortz, 
2000). The strongest evidence to date that there is a putative TFF2 receptor is work from 
Dubeykovskaya et al. Dubeykovskaya et al demonstrated in vitro that TFF2 requires 
CXCR4 for calcium mobilization, ERK1/2 activation, and AKT activation, two 
downstream signaling cascades of Trefoils (Dubeykovskaya et al., 2009). Additionally, 
Engevik et al demonstrates that Tff2 deficient gastric organoids have delayed repair 
following injury and that inhibition of CXCR4 in the presence of exogenous TFF2 was 
unable to rescue repair (Engevik et al., 2019). Interestingly, these data never show direct 
binding between CXCR4 and TFF2 using standard binding assays such as co-
immunoprecipitation, proximity ligation assays, or surface plasmon resonance (Drescher 
et al., 2018; Kaboord and Perr, 2008; Weibrecht et al., 2010). Furthermore, these studies 
do not demonstrate that Cxcr4 deficient mice phenocopy Tff2 deficient mice, a result that 
would be hypothesized to occur without either the receptor or ligand. 
 Recent evidence has demonstrated that TFF3 interacts with leucine rich repeat and 
immunoglobulin-like domain- containing nogo receptor-interacting protein 2 (LINGO2) to 
regulate epidermal growth factor receptor (EGFR) activation (Belle et al., 2019). Belle et 
al. demonstrated that TFF3 and LINGO2 directly bind using co- immunoprecipitation and 
proximity ligation assays, are colocalized and expressed on the cell surface of transfected 
TFF3 or LINGO2 cells (Belle et al., 2019). Furthermore, this work demonstrates that 
LINGO2 can bind to EGFR and administration with TFF3 reverses that binding (Belle et 
al., 2019). These data were the first in vitro and in vivo evidence of a putative TFF3 binding 
partner, additionally, LINGO2 was a protein that previously had no known function. 
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The LINGO family of proteins 
 Leucine rich repeat and immunoglobulin-like domain-containing nogo receptor- 
interacting proteins are a family of four homologous receptors (LINGO1-4). The LINGO 
proteins are Type 1 transmembrane proteins that contain 12 extracellular leucine rich 
repeats, an immunoglobin C2 domain, and an intracellular cytoplasmic tail (Haines and 
Rigby, 2008). The LINGOs have different expression patterns within mouse tissues; 
however, all four proteins are expressed during embryogenesis ranging from 8.5 days post 
coitum (dpc) to 10.5 dpc (Haines and Rigby, 2008). Interestingly, in adult mice the 
expression patterns of each LINGO family member are different while LINGO1 is highly 
expressed within the brain and spinal cord, LINGO 2-4 are expressed within the GI tract 
in addition to the central nervous system (Belle et al., 2019; Haines and Rigby, 2008). 
Prior to the work from the Herbert lab investigating the role of LINGO2 in the GI tract, 
LINGO1 was the only family member that had been studied. LINGO1 has been shown to 
form a complex with two other proteins, NOGO-66/p75 neurotrophin receptor complex. 
Upon forming a ternary complex, the proteins can signal to promote myelin inhibition (Mi 
et al., 2004). Furthermore, upon deletion or blocking of LINGO1 there is enhanced survival 
of dopaminergic neurons (Inoue et al., 2007). Interestingly, the cytoplasmic domain of 
LINGO1 contains a canonical EGFR tyrosine phosphorylation site, suggesting that this 
protein/protein complex can interact and regulate EGFR signaling (Mi et al., 2004); (Inoue 
et al., 2007). Inoue et al. demonstrated that LINGO1 and EGFR directly bind and that 
LINGO1 decreases EGFR in a dose dependent manner (Inoue et al., 2007). Taken together 
these data demonstrate that LINGO1 forms a ternary complex to elicit a signaling response 
that inhibits neuronal outgrowth (axon regeneration) through downregulation of growth 
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factor signaling and promote myelin inhibition. Because the LINGO family members have 
60-90% sequence homology, it is possible that the other LINGO family members also work 
in a complex to promote/ inhibit EGFR signaling and regeneration (Haines and Rigby, 
2008; Mi et al., 2004). 
 Recent work from Belle et al. demonstrates that LINGO2 is expressed within the 
GI tract of humans and can bind to EGFR, similar to LINGO1, as well as TFF3 (Belle et 
al., 2019). Furthermore, LINGO2 was necessary for TFF3 induced cell survival as well as 
STAT3 and EGFR activation, such that Lingo2 deficient mice had excess intestinal EGFR 
activation and worsened colitis (Belle et al., 2019). These data in support with the work on 
LINGO1 suggest that the LINGO family members interact in a complex to regulate growth 
and regeneration, regardless of the tissues that the proteins are expressed in. However, 
further studies will need to be performed to better understand the roles of LINGOs in the 
GI tract and their putative roles in wound repair during mucosa injury. 
1.4 The effects of a defective gastrointestinal barrier 
Microbial driven defects of gastrointestinal barrier: Leaky gut syndrome 
 The previous sections have discussed the regulatory mechanisms and major 
proteins involved in controlling the maintenance and homeostasis of the GI barrier. 
However, understanding how defects in the GI barrier drives intestinal diseases is crucial 
for better understanding of the current paradigm as well as novel mechanisms that regulate 
intestinal inflammation and barrier dysregulation. As previously described, commensal 
bacteria live in close proximity to the mucosa of the GI tract. Work from Earle et al has 
demonstrated that within the mucosa, dietary changes can lead to thinning of the mucus 
layer and increased inflammation (Earle et al., 2015). Interestingly, in germ- free mice, 
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when diets have reduced microbiota accessible carbohydrates, commensals are in closer 
proximity to the epithelium (Earle et al., 2015). Dietary changes are just one environmental 
cue that can lead to dysregulated mucosa, non-steroidal anti-inflammatory (NSAID) use, 
alcohol use, bacterial infections, and chronic inflammation can all lead to commensals 
entering into the gastrointestinal mucosa (Berkley et al., 2005; Maseda et al., 2019; Nieman 
et al., 2006; Purohit et al., 2008). Because commensals live in symbiosis with the host it is 
thought that these symbionts are tolerogenic, preventing the immune system from 
recognition of these bacteria and eliciting an immune response against commensals. In the 
context of inflammation or a barrier breach, commensal specific T cells can induce memory 
specific immune responses; however, the exact implications for this is not well studied 
(Atarashi et al., 2011; Hand et al., 2012; Ivanov et al., 2009). 
 Citrobacter rodentium (C. rodentium), is a Gram-negative enteropathogenic 
bacteria, that infects rodents and is the homologue to human enteropathogenic Escherichia 
coli (E.coli). C. rodentium is a member of the attaching and effacing (A/E) bacteria family 
and contains the locus of enterocyte effacement (LEE) (Deng et al., 2001). LEE encodes a 
Type III secretion system and the genes necessary to form the A/E lesion, an actin rich 
pedestal that forms on the plasma membrane of hosts’ intestinal epithelial cells (Deng et 
al., 2003; Schauer and Falkow, 1993a, b). Upon pedestal formation C. rodentium secretes 
bacterial proteins, such as espB, that are necessary for bacterial colonization (Deng et al., 
2001; Liu et al., 1999; Newman et al., 1999). Upon infection the bacteria colonize the 
caecum and are shed within the feces (Wiles et al., 2004). Following colonization, C. 
rodentium disrupts the tight junction integrity, leading to commensal bacteria 
dissemination into the lamina propria, which causes massive inflammation and pathology 
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(Flynn and Buret, 2008; Garber et al., 2018; Guttman et al., 2006; Thanabalasuriar et al., 
2013). Additionally, because this bacterium is shed in the feces, coprophagia leads to 
continual infection in rodents and dissemination of bacteria to the large and small intestine 
(Johansson et al., 2008; Wiles et al., 2006). 
 Upon colonization and dissemination C. rodentium induces a TH17 and TH1 
immune response, colonic hyperplasia (thickening of the colon), and diarrhea (Fig 1.4). 
Work from Simmons et al demonstrate that both CD4+ T cells and B cells are crucial for 
immunity against C. rodentium, however CD8+ T cells are dispensable (Simmons et al., 
2003). Recent work from Sonnenberg et al has demonstrated the during the early 
timepoints of infection, two innate immune responses are critical for early control; ILC3 
and LTi cellular responses (Sonnenberg et al., 2011). C57BL/6 mice can excrete and clear 
C. rodentium typically within 3 weeks of infection, however genetic deficiencies of proper 
TH17 or TH1 immune responses lead to death (Wiles et al., 2004; Wiles et al., 2006). 
Importantly, because C. rodentium causes colonic hyperplasia as well as localized 
inflammation within the GI tract, it is a system used to model Crohn’s disease, Ulcerative 
Colitis, as well as colon tumorigenesis (Chandrakesan et al., 2014; Higgins et al., 1999). 
Inflammatory bowel disease: subsets and model systems 
 Inflammatory bowel disease (IBD) is a chronic inflammatory disease of the GI tract 
that is further categorized into two subsets Crohn’s disease (affects any region of the GI 
tract) and Ulcerative colitis (limited to colon) (Fakhoury et al., 2014). Within the United 
States, approximately 3 million people have inflammatory bowel disease (Dahlhamer et 
al., 2016). Although this disease was first defined in the 1930s, there is no cure (Feuerstein 
and Cheifetz, 2017). Patients typically present with weight loss, diarrhea, bloody stool, 
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abdominal pain, fatigue, and/or fevers with the median age of onset being 30 (Burgmann 
et al., 2006; Cheifetz, 2013; Dahlhamer et al., 2016). 
 Although the causative effect of IBD is not well understood, it is thought that 
environmental factors such as stress and GI infections as well as genetic risk factors 
including familial risk, mutations in pattern recognition receptors like nucleotide-binding 
oligomerization domain containing protein 2 (NOD2), and defects in signaling pathways 
involved in epithelial function and adaptive immunity are all contributing factors (Cleynen 
et al., 2016; Hugot et al., 2001; Loftus, 2004; Ng et al., 2013; Ogura et al., 2001). To date, 
there are few treatment options available to patients. Treatments can include blockade of 
the inflammatory signaling pathways such as anti-IL12/23 or anti- TNF, as well as surgical 
re-sectioning of the GI tract in the affected region (Chateau and Peyrin-Biroulet, 2019; 
Feuerstein and Cheifetz, 2017; Ribaldone et al., 2019; Sands et al., 2019). To better 
understand the pathogenesis of this disease and further develop potential curative therapies, 
more research needs to be undertaken. 
 There are a number of different model systems used to study IBD. As previously 
discussed, C. rodentium is one of these model systems, however, another model system is 
dextran sodium sulfate (DSS) administration (Fig 1.4). DSS can be given in a number of 
quantities ranging from 1-5%, with 5% leading to the most inflammatory injury and 1% 
leading to the least inflammatory injury(Chassaing et al., 2014). The exact mechanism of 
how DSS induces intestinal inflammation is unknown, however, it is expected that 
inflammation is an effect of the denudation of epithelium caused by administration of the 
chemical. Upon administration, mice typically begin to lose weight around day 3 post 
administration and show signs of clinical manifestations of disease (diarrhea, bloody stool, 
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lack of grooming, weight loss) (Chassaing et al., 2014). The amount of DSS administered 
can be variable depending on the question being asked, for example to evaluate a relapsing 
IBD similar to what is observed in Crohn’s patients, a lower DSS dose will be administered 
for 6 days, then stopped and started again 4-6 days afterwards (Chassaing et al., 2014; 
Fakhoury et al., 2014). However, if evaluating the onset of IBD and specifically the 
signaling molecules/ pathways involved in repair and regeneration, DSS is administered 
for 6 days where the mice show clinical manifestations of disease and then returned to 
normal drinking water for 4-6 days in order to allow for reduced inflammation and recovery 
from injury (Chassaing et al., 2014; Fakhoury et al., 2014). Because DSS denudes the 
epithelium, Lgr5+ stem cells are necessary for repair (Davidson et al., 2012). Additionally, 
recent studies have shown that Paneth cells play a major role in epithelial regeneration 
during DSS (Schmitt et al., 2018). Furthermore, TFFs have been shown to be increased 
following DSS administration and have implications in recovery (Judd et al., 2015; Renes 
et al., 2002). Importantly, DSS has typically been implicated as a myeloid-driven model 
because this model remains intact when T and B cell deficiency mice are used (Kim et al., 
2006). However, IL-10 secretion from T-reg cells can promote tissue recovery (Guo et al., 
2019; Yang et al., 2019a). Following administration, DSS leads to immune infiltration, 
namely myeloid cells, smooth muscle hyperplasia, and a decrease in colon length, all 
clinical symptoms observed in IBD patients (Chassaing et al., 2014; Fakhoury et al., 2014). 
During the recovery phase, goblet cells can be found replenishing the colon, as well as an 
induction of stem cell activity. 
 Although oral administration of DSS was originally hypothesized to drive colon 
specific injury reflective of Ulcerative colitis, recent studies have shown that DSS can also 
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cause epithelial denudation and inflammation in small intestine.  This indicates that DSS 
can also be used as a representative animal model of Crohn’s disease that affects more 
proximal regions of the GI tract (Geier et al., 2009; Yazbeck et al., 2011). The usage of 
DSS in animal models has allowed for a better understanding of the role myeloid cells have 
in IBD as well as development of treatments such as anti-IL-12/23 for IBD. However, a 
benefit of the DSS model is that one can specifically study the immune mechanisms behind 
the recovery phase, unlike any of the other IBD models such as T-cell driven colitis. Mice 
deficient in AJC proteins such as E-cadherin or Claudin-2 are more susceptible to DSS 
colitis with increased ulcerations and a loss of crypt architecture and regeneration (Grill et 
al., 2015; Nishida et al., 2013). Additionally, during DSS administration mice lose 
expression of ZO-1 by day 7 post administration (Poritz et al., 2007). Interestingly, 
overexpression of claudin-2 can protect against colitis, further supporting the evidence that 
tight junction proteins are crucial during recovery of DSS (Ahmad et al., 2014). 
Understanding the recovery phase of colitis is crucial not only to identify better treatment 
options for these patients, but also for the development of a putative cure for these patients. 
1.5 Overview 
 The work comprising this dissertation reveals a novel role for the orphan Type 1 
transmembrane receptor LINGO3 as a regulator of the GI epithelium during homeostasis 
and post injury in promoting GI tissue recovery during DSS-induced colitis. Chapter 2 
demonstrates that Lingo3 is expressed in at three different mucosal sites, the ileum, colon, 
and lung, and is exclusively expressed on intestinal epithelial cells isolated from the small 
intestine and colon. LINGO3 is not expressed on immune cell subsets isolated from the 
MLN or spleen. Interestingly, in rectosigmoid samples from healthy human subjects, 
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LINGO3 is expressed in at least two locations: 1) on the apical surface of the GI tract where 
enterocytes are located and 2) on cells within the base of the intestinal crypt where the 
intestinal stem cell niche is located. Upon deletion of Lingo3, there is an increase in 
intestinal permeability that is most likely due to dysregulated adherens junctions.  This 
conclusion is based on data generated by electron microscopy, revealing  a decrease in 
Cdh1 and Itgae, which are genes known as essential components of the adherens junction.  
On a protein level, the data show that Lingo3 deficient mice have a decrease in E-cadherin 
. Furthermore, the lack of Lingo3 also results in a dysregulation in mucosal barrier 
formation accompanied by an increased number of DCs and increased in frequency of TH1 
cells within GI tissues and mesenteric lymph node tissues.  
 To assess if LINGO3 was important for tissue repair following colitic injury, co-
housed WT and Lingo 3 KO mice were administered a moderate dose of DSS. Lingo3 
deficient mice had an increased severity of DSS-induced colitis associated with an increase 
in morbidity as determined by weight loss, increased clinical score, decreased colon length, 
lack of crypt architecture, and delayed goblet cell replenishment. Because Lingo3 deficient 
mice displayed a similar phenotype to Tff2 deficient mice during DSS-induced colitis, 
experiments were designed to assessed if TFF2 and LINGO3 were functioning in a similar 
pathway. Indeed, data generated in chapter 2 demonstrate that although we do not have 
strong evidence that TFF2 and LINGO3 directly bind to each other, we successfully 
demonstrated that TFF2 promoted a faster recovery during DSS-induced colitis in WT 
mice, but not in Lingo3 deficient mice. This enhanced recovery with TFF2-Fc 
administration correlated with  enhanced activation of ERK in WT mice but not in Lingo3 
KO mice.  
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 My work  demonstrates that LINGO3 and TFF2 signaling pathways seems to have 
a beneficial role in the proper maintenance and/or function of the intestinal stem cell niche.  
This contention comes from data that demonstrate a growth and architectural defect within 
Lingo3 and Tff2 deficient organoids when compared to WT organoids. These data are 
consistent with the defects in tissue recovery following DSS-induced colitis observed in 
both Lingo3 and Tff2 deficient mouse strains.  
  Chapter 3 demonstrates that Lingo3 deficiency does not confer resistance or 
susceptibility to the enteropathogenic bacterium, C. rodentium.. These data are somewhat 
surprising given that Lingo3 deficiency increased the basal level of Type 1 cytokine 
production, which is generally thought responsible for promoting host protection against 
microbes. Overall, the work in this dissertation has important implications for expanding 
the body of knowledge pertinent to epithelial cell signaling and function within the GI 
mucosa, which are topics discussed in greater detail within Chapter 4. Moreover, that  
LINGO3 was demonstrated herein to possess important functional roles within the 
intestinal stem cell niche, formation of the adherens junction, and recovery from colitic 
injury are major areas that require further investigation in future studies beyond the work 
completed in this dissertation. The implications for LINGO3 within these three areas will 
be discussed in Chapter 4. It is important to note, that the work in the remaining factors 
focuses strictly on the GI tract, however, LINGO3 and TFF2 have been shown to be 
expressed in other mucosa such as the lung (Belle et al., 2019; Wills-Karp et al., 2012), 
therefore additional implications of this work extent to mucosal surfaces outside of the GI 




           
Figure 1.1 The intestinal epithelium forms the barrier between the mucus layer 
(green) and the lamina propria (beige). The epithelium is composed of anti-microbial 
peptides, mucins, and commensals which are present in the lumen of the GI tract. Goblet 
cells, and enterocytes compose the majority of the intestinal epithelial cells while Lgr5+, 
Paneth, and transit amplifying cell compose the stem cell niche. 
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Figure 1.2 Schematic of the apical junction complex composition. The apical junction 
complex is comprised of claudins, occludens, zonula occludens, junctional adhesion 
molecules (JAMs), and the adherens junctions, which are positioned on the basolateral side 
of enterocytes and anchor to the actin cytoskeleton. The adherens junctions consist of E- 




Figure 1.3 Immune cell subsets that comprise the lamina propria. Under inflammatory 
conditions, professional antigen presenting cells (dendritic cells and macrophages), 
propagate a specific immune response (Type 1 Vs Type 2), activated T cells (TH1, TH2, 
TH17, TH22, TH9) produce cytokines (indicated by arrows). Furthermore, innate 
lymphoid cells (ILC1-3) can elicit TH1, TH2, TH17 immune responses, following tissue 
injury or infection with various types of organisms (pathogenic or commensal). During 
steady state conditions, these immune cells are considered largely tolerogenic and fail to 





Figure 1.4 Two different types of gastrointestinal injury. 1) Infection with the 
enteropathogen C. rodentium results in an A/E lesion on intestinal epithelial cells. Post-
A/E lesion formation, C. rodentium secretes bacterial proteins into the lamina propria 
resulting in the disruption of tight junctions between epithelial, which can allow 
commensal organisms to enter into the lamina propria. The colonization with C. rodentium 
together with commensals entering into the lamina propria culminates in development of a 
robust a Type 1 immune response. 2) Following administration of the toxic carbohydrate 
dextran sodium sulfate (DSS), the intestinal epithelium is severely damaged resulting in 
exposure of the basement membrane. This denudation of the epithelium induces 
macrophages and DCs to secrete IL12/23p40 and TH1 cells to secrete IFNg and TNF. 
Furthermore, macrophages as well as Treg cells secrete IL-10 to control the inflammation. 
Lgr5+ stem cells, Paneth cells, and TFF secreting goblet cells are necessary for regeneration 
of intestinal architecture during the recovery phase of DSS-induced colitis.  
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Chapter 2: LINGO3 enforces mucosal barrier integrity and controls tissue repair 
during colitis 
Abstract 
Mucosal epithelia are exposed to potentially damaging stimuli, yet pathways that restore 
homeostasis following injury remain incompletely known. Herein, we show that the 
transmembrane receptor, leucine rich repeat and immunoglobulin like domain containing 
nogo receptor interacting protein 3 (LINGO3) is necessary for mucosal integrity and tissue 
regeneration following dextran sodium sulfate (DSS)-induced colitis. In humans, upper 
respiratory and intestinal epithelia express LINGO3 near Trefoil factor 2 (TFF2). In naïve 
mice, Lingo3 deficiency impairs E-cadherin expression, increases microbial translocation 
and accumulation of activated intestinal dendritic and TH1 cells. TFF2 administration 
accelerated healing post-DSS in wildtype, but not Lingo3 knockout mice. TFF2-driven 
protective effects like ERK1/2 activation, were LINGO3 dependent, but regulation of 
caspase-3 and Ki-67 were LINGO3 independent. Either TFF2 or LINGO3 deficiency 
impaired budding/growth of gastrointestinal organoids and reduced expression of Lgr5. 
Combined, we propose LINGO3 as a novel regulator of intestinal integrity and 
regeneration under steady-state and injurious conditions. 
Introduction 
Diverse epithelial cell lineages form a dynamic protective barrier to the external 
environment and form a semi-permeable shield for the body against mechanical, chemical, 
and organismal injury (Oshima and Miwa, 2016; Yu, 2018). Tissue injury, particularly in 
the gastrointestinal (GI) tract initiates mobilization of epithelial progenitors in the crypt 
stem cell niche, and changes the gene expression profiles of enterocytes, M cells, goblet 
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cells, enteroendocrine cells, Paneth cells, and tuft cells (Andersson-Rolf et al., 2017; 
Peterson and Artis, 2014; Yen and Wright, 2006). Epithelial secretions including cytokines 
to reactive nitrogen and oxygen intermediates and lipid mediators protect mucosal tissues 
against invasion by organisms to curtail inflammation and further promote repair, but the 
knowledge of these soluble mediators is incomplete (Glover et al., 2016; Ortiz-Masia et 
al., 2010; Peterson and Artis, 2014). Notably, the Trefoil factor family (TFF1, TFF2, TFF3) 
peptides drive largely enigmatic pathways of tissue repair and immunoregulation at the 
mucosal interface (Aihara et al., 2017). TFFs are constitutively present within mucus 
secretions and regulate epithelial biology through restitution, cellular migration, regulation 
of tight junction proteins, and inhibition of epithelial cell apoptosis, but how these proteins 
exert their function(s) remains unclear (Cai et al., 2016; Hanisch et al., 2017; Hung et al., 
2018; Le et al., 2016). 
 TFFs may promote wound healing through receptor-mediated signal transduction 
events and/or indirectly by modifying the rheological properties of mucus (Aihara et al., 
2017; Thim and Mortz, 2000; Yong et al., 2013). CXCR4, (the stromal derived factor 1 
(SDF-1) receptor), responds to TFF2 at high concentrations (Dubeykovskaya et al., 2009). 
However, there is no data from in vivo experimentation to indicate that CXCR4 deficiency 
impairs tissue repair. We and others have found that Tff2 deficient mice (Tff2 KO) have 
worsened disease post dextran sodium sulfate (DSS) colitis, increased pro-inflammatory 
cytokine secretion IFNg, IL-6, IL-1b, and inducible nitric oxide synthase (iNOS) as well 
as defective mucosal barrier integrity under baseline conditions, but no such data have been 
reported for CXCR4 deficiency (Judd et al., 2015; Kurt-Jones et al., 2007; McBerry et al., 
2012). Thus, we sought to identify and characterize extracellular transmembrane proteins 
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that upon deletion, would recapitulate features of TFF2 deficiency. 
 This study provides evidence that the orphan receptor leucine rich repeat and 
immunoglobulin like domain containing nogo receptor interacting protein 3 (LINGO3) 
functions in mucosal tissue repair and is partially responsible for TFF2 responsiveness. 
Although TFF2 and LINGO3 weakly interact, our loss of function studies shows that 
Lingo3 knockout (Lingo3 KO) mice display basal defects in intestinal mucosal barrier 
integrity, defective E-cadherin expression, and inflammatory cell accumulation. Also, 
Lingo3 KO and Tff2 KO strains had cell-intrinsic defects in intestinal organoid formation 
and defective recovery from DSS- induced colitis. Therapeutic TFF2-Fc administration 
accelerated healing following colitic disease in WT, but not in Lingo3 KO mice, which 
together indicates that LINGO3 is a novel reparative protein that regulates mucosal 
epithelial cell biology.  
Results 
Identification of LINGO3 as a mucosal epithelial protein in mice and humans. 
 Despite reports implicating CXCR4 in TFF2-mediated signal transduction, there 
have been no reports validating a TFF2-CXCR4 axis in vivo. (Dubeykovskaya et al., 2009) 
Therefore, we employed the TRICEPs approach (Frei et al., 2012; Frei et al., 2013) using 
human rTFF2 as bait to identify potentially novel extracellular membrane-associated 
proteins. Results from this screen led us to focus on the type 1 transmembrane orphan 
receptor LINGO3 that contains a 40 amino acid (AA) cytoplasmic tail containing two 
serines and one tyrosine residue (Fig. 2.1a). To study LINGO3 in detail, a CRISPR-CAS9 
gene-editing approach was used to generate Lingo3 deficient mice. Lingo3 specific 
sgRNAs were generated to target the translational start site in exon 2 and injected into 
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C57BL/6 blastocysts with CAS9 protein. A founder line with a heterozygous 70 bp deletion 
downstream of initiator ATG was identified, outcrossed to C57Bl/6 WT mice, then bred to 
homozygosity, and confirmed to lack off-target deletions using SNP analysis (Fig 2.2a-e). 
TaqMan assays were used to determine Lingo3 mRNA expression levels in naïve wildtype 
(WT) and Lingo3 knock out (Lingo3 KO) biopsies taken from lung, small intestine and 
colon. Lingo3 mRNA transcripts were readily evident in WT, but not Lingo3 KO (Fig. 
2.1b). Lingo3 mRNA transcripts were also detected using SYBR green assays in liver, 
spleen, brain, and heart, but not in the bone marrow or kidney (Fig 2.2f). On a cellular 
basis, isolated intestinal epithelial cells (IEC) had Lingo3 expression, but not CD4+ (T 
cells), B220+ (B cells), or CD11b+CD11c+ (myeloid cells) (Fig. 2.1c). Although we tested 
for LINGO3 protein levels using several commercially available and in-house generated 
anti-mouse LINGO3 antibodies, none were found to be specific. However, a validated anti-
human LINGO3pAb was employed to ask  whether LINGO3 was expressed on human 
intestinal epithelia. Co-immunofluorescence staining using anti-human LINGO3 pAb  and  
anti-human  TFF2  pAb  (to  identify goblet cells) on formalin fixed paraffin embedded  
(FFPE)  rectosigmoid  specimens  from normal human subjects was used to determine if 
LINGO3 was expressed in the vicinity of TFF2. TFF2 (red) localized to goblet cells within 
intestinal crypts, whereas LINGO3 (green)  was  expressed  on  colonic  enterocytes  and  
sparsely  along  crypt base with no staining in the isotype-matched Ab controls (Fig. 2.1d-
i). The expression of LINGO3 protein along the crypt base is consistent with previous 
reports suggesting that Lingo3 mRNA is expressed on Lgr5+ cells and transit-amplifying 
cells (Haber et al., 2017; Hsu et al., 2014; Rangel-Huerta and Maldonado, 2017). To 
evaluate other mucosal epithelia surfaces, we stained nasal polyp tissues obtained from 
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patients with chronic rhinosinusitis (Kohanski et al., 2018; Patel et al., 2018; Workman et 
al., 2018). Data revealed LINGO3 (green) expression on epithelia in a spatially distinct 
pattern from the punctate TFF2 (red) staining inside of goblet cells, with no staining in the 
isotype matched Ab control (Fig. 2.1j-n). These data suggested that LINGO3 was 
expressed on mucosal epithelia in the vicinity of goblet cell derived TFF2.  
TFF2 weakly interacts with LINGO3. 
 We postulated that if TFF2 interacted with LINGO3, then we should be able to 
demonstrate TFF2-LINGO3 localization at the cell membrane and TFF2-mediated 
restitution in a LINGO3 dependent manner (Aihara et al., 2017; Dubeykovskaya et al., 
2009; Engevik et al., 2019; Hung et al., 2018). To determine if TFF2 and LINGO3 would 
interact at the cell membrane, flow cytometry was used to establish whether over- 
expression of LINGO3-GFP, LINGO2-GFP, or CXCR4-GFP fusion constructs transfected 
into HEK293 cells would allow binding to soluble, recombinant (r)TFF2 (TFF2-647), Ctrl 
Ig (IgG-647), or rSDF-1 (SDF-1-647) (Fig. 2.3a-b). Data show a 6-10 fold higher 
frequency of TFF2-647-bound to LINGO3-GFP transfectants than TFF2-LINGO2 
transfectants or TFF2-CXCR4 transfectants, respectively (Fig. 2.3c-f). There was 
negligible binding with IgG-LINGO3 control. The frequency of TFF2-bound LINGO3- 
GFP transfectants was slightly lower than the frequency of double positive SDF-1-647 
CXCR4-GFP cells, which had the highest frequency of binding in this assay as expected 
for a known receptor-ligand interaction (Fig. 2.3g). As an alternative approach, co- 
immunoprecipitation experiments were performed to test whether Flag-tagged LINGO3 
would bind to affinity-purified TFF2-Fc-fusion protein (Fig. 2.3h). To do this, CHO cells 
were transfected with either empty vector or Flag-tagged LINGO3 for 72hrs, lysed and 
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complexed with soluble Fc or TFF2-Fc followed by protein G pulldown and 
immunoblotting against the Flag epitope. A moderate signal was detected in the TFF2-
LINGO3 sample, but not with Fc only, indicating a weak interaction (Fig. 2.3i-j). We 
reasoned that if TFF2 mediated signals required LINGO3, then Lingo3 deficient epithelial 
monolayers should be deficient in restitution, a hallmark of TFF biological activity 
(Engevik et al., 2019; Hung et al., 2018; Meyer zum Buschenfelde et al., 2006). Therefore, 
WT and Lingo3 KO monolayers of primary sinonasal epithelial cells grown under air-
liquid interface conditions were subjected to scratch wound assays ±rTFF2 (Lee et al., 
2014) (DePoortere et al., 2013). Changes in initial trans-epithelial electrical resistance 
(TEER) values were used to evaluate differences in barrier integrity. After the scratch, 
TEER rebound values in rTFF2-treated WT cultures were significantly increased, but there 
was no impact on Lingo3 KO epithelia (Fig. 2.3k). These data indicated TFF2 promoted 
barrier restoration in a LINGO3 dependent manner. 
Lingo3 deficiency increases TH1 cell frequency and disrupts mucosal barrier 
integrity. 
 Mucosal epithelia and microbial communities are in a bi-directional 
communicative circuit, with perturbations on either side resulting in inflammation- 
associated tissue pathology (Nowarski et al., 2015; Thiemann et al., 2017). To test whether 
Lingo3 deficiency could potentially disrupt intestinal barrier integrity in vivo, cohorts of 
WT and Lingo3 KO mice were orally inoculated with 440mg/kg of FITC-dextran (4 kDa) 
and serum levels of fluorescence were measured as a surrogate for paracellular intestinal 
permeability (Joly Condette et al., 2014; Patel et al., 2012; Wang et al., 2015; Woting and 
Blaut, 2018). Strikingly, Lingo3 KO mice had 3-fold greater FITC-dextran levels than WT 
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controls (Fig. 2.4a). To evaluate the intestinal microbiome, microbial composition of fecal 
pellets collected from naïve WT and Lingo3 KO mice were analyzed using 16S rRNA gene 
sequencing. There was a moderate change in microbial composition between strains (Fig. 
2.5a), but there were no overt pathophysiological or obvious histological differences in 
colon or small intestine tissues between strains at 6-9 weeks old (Fig. 2.4b and Fig. 2.5b-
c). There was no evidence of colon shortening in naïve Lingo3 KO mice (Fig. 2.5d). 
 We surmised that basally impaired barrier integrity in Lingo3 KO mice would lead 
to bacterial translocation. Indeed, serum endotoxin levels were 3-fold higher in Lingo3 KO 
mice compared to WT (Fig. 2.5e). Because increased endotoxin levels can initiate 
inflammation, we used flow cytometry to quantify different myeloid antigen presenting 
cell (APC) populations (macrophages (M	Ø) and dendritic cells (DC)) within mesenteric 
lymph nodes (MLN) of WT vs. Lingo3 KO mice (Fig. 2.6a). There was a statistically 
significant increase in the number of CD11c+ MHCII+ (activated DC) cells within Lingo3 
KO mice compared to co-housed WT (Fig. 2.4c-d). Within the activated DC pool, the 
number, of CD103+XCR1+, XCR1+CD103-, and XCR1-CD103-SIRPa+ cell subsets, were 
all significantly increased in Lingo3 KO mice as compared to WT (Fig. 2.4e- j). This was 
interesting since XCR1+CD103+ and SIRPa+ are known markers for conventional dendritic 
cell type 1 and type 2 (cDC1 and cDC2), respectively (Guilliams et al., 2016). There were 
no differences in CD103+XCR1- DC or CD64+ tissue M	Ø (Fig. 2.6b-g). 
 Because the CD103+XCR1+ (cDC1) subset can drive Type 1 immune responses we 
also evaluated the frequency and number of activated/effector TH1 cells defined by CD44 
expression and intracellular staining for IFNγ and TNF (Fig. 2.6h) (Guan et al., 2009; 
Harpur et al., 2019). Both IFN-γ+ and TNF+ frequencies within MLN CD4+ 
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effector/memory (CD44HI CD62LLO) and central memory (CD44HI CD62HI) populations 
were significantly higher in Lingo3 KO as compared to WT (Fig. 2.4k-m). IFNγ+TNF+ 
CD4+T cells within the colon lamina propria were also significantly increased in Lingo3 
KO compared to WT (Fig. 2.4n). There were no differences between strains in the 
CD44LOCD62LHI naïve CD4+ T cell gate (data not shown). No differences were observed 
in effector/memory CD8+ T cells (data not shown). This indicated that Lingo3 deficiency 
increased Type 1 immune responses within the large intestine and regional lymph nodes 
under steady-state conditions. 
Lingo3 KO mice have micro-anatomical defects in the adherens junction region of 
intestinal epithelial cells. 
 Endotoxin leakage from the gut indicated potential defects in IEC cell-cell 
adhesion. Transmission electron microscopy (TEM) was used to evaluate IEC junctional 
regions under steady-state conditions. As expected, WT IECs within jejunum and colon 
displayed closely apposed junctional regions with a clearly evident apical junction 
complex. In contrast, IECs of Lingo3 KO mice displayed aberrantly wide and disordered 
junctional spaces consistent with defective IEC barrier capability (Fig. 2.7a-b). Consistent 
with this hypothesis, quantification of Cdh1(E-cadherin) mRNA transcript levels revealed 
significantly decreased Cdh1 transcripts in Lingo3 KO colons compared to WT controls 
(Fig. 2.7c ). Because E-cadherin is known to bind and interact with integrin alpha e (CD103 
encoded by Itgae), an integrin expressed on both epithelial cells and dendritic cells 
(Schlickum et al., 2008; Van den Bossche et al., 2012), we also measured Itgae mRNA 
transcripts, revealing that Lingo3 deficiency also reduced Itgae levels (Fig. 2.7d). 
Strikingly, E-cadherin protein levels in colon tissue were markedly reduced in Lingo3 KO 
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compared to WT as determined by western blotting (Fig 2.7e-f). Together, this indicated 
that Lingo3 deficiency in mice significantly disrupted efficient IEC barrier function. 
Lingo3 KO mice have enhanced sensitivity to DSS induced colitis and epithelial 
intrinsic defect in intestinal stem cell gene expression. 
 Given these basal defects in structural integrity and mild inflammatory cell 
activation caused by Lingo3 deficiency under steady-state conditions, we next asked 
whether these animals had increased susceptibility to DSS-colitis or defects in the healing 
response following cessation of DSS treatment (Rani et al., 2011). Age-matched, co- 
housed cohorts of WT and Lingo3 KO mice were administered 2.5% DSS ad libitum in the 
drinking water over 6 days, then returned to normal drinking water and monitored for an 
additional 4 days for weight change and disease activity index (DAI) to study the early 
recovery phase. While on DSS (day 0-5) there were no significant differences in weight 
change, DAI score, or histological appearance between Lingo3 KO and WT mice. In 
contrast, starting on day 6 when DSS was removed, Lingo3 KO mice began to show 
histological signs of worsened disease, albeit not statistically significant (Fig. 2.8a-j). 
During the healing phase following the cessation of DSS treatment, Lingo3 KO mice failed 
to regain body weight (Fig. 2.9a, Fig. 2.10a) and had increased DAI scores compared to 
WT mice that gained weight and decreased their DAI scores (Fig. 2.9b). Colon lengths 
were shorter in Lingo3 KO mice compared to WT on day 10 (Fig. 2.9c). Furthermore, 
Lingo3 KO mice had worsened pathology as determined by histological evaluation on day 
10 (Fig. 2.9d-e). 
  Additionally, we used periodic acid Schiff base (PAS) staining to identify mucin 
positive goblet cells in the colon following DSS treatment as proxy for stem cell niche 
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output. Although 4 days was sufficient time for WT mice to re-populate their colonic goblet 
cells, Lingo3 KO mice had persistent defects, with few sparse patches of goblet cells (Fig. 
2.9e-f). Consistent with a defect in stem cell output, mRNA expression for leucine-rich 
repeat-containing G-protein coupled receptor 5 (Lgr5), an IEC stem cell gene necessary 
for colonic recovery from DSS treatment (Koo and Clevers, 2014), was significantly lower 
in Lingo3 KO mice as compared to WT under both basal and post-DSS treatment 
conditions (Fig. 2.10b). 
 To address whether Lingo3 deficiency caused an intrinsic defect of intestinal stem 
cell (ISC) activity apart from the collateral damage due to cell-cell adhesion defects, 
enhanced inflammation, and Type 1 cytokines, we used an intestinal organoid in vitro 
culture system (Sato et al., 2009). First, small intestinal organoids were grown over 7 days 
and evaluated for budding and overall size as surrogate indicators of ISC activity (Fig. 
2.11a). Both Lingo3 KO and Tff2 KO mice had a 2-4 fold defect in overall organoid 
budding as well as a decrease in size (Fig. 2.11b-c, Fig. 2.10c-d). Congruent with this 
interpretation, Lgr5 mRNA expression levels in Lingo3 KO and Tff2 KO organoids were 
significantly lower than WT (Fig. 2.11d). Lingo3 KO organoids had decreased Tff2 
expression levels, while Tff2 KO organoids had an additional decrease in Tff3 expression 
(Fig. 2.10e). Second, when we evaluated colonic organoids grown over 7 days, we 
observed that while Lingo3 KO organoids had increased budding compared to WT, Tff2 
KO organoids had no difference relative to WT (Fig. 2.10f , Fig. 2.11e-f). Interestingly, 
however, over 7 days of culture, both Lingo3 KO and Tff2 KO organoids had a loss in the 
3D architecture and instead became flattened and 2D when compared to WT organoids 
(Fig. 2.10g, Fig 2.11e, g). This flattened appearance is consistent with epithelial- 
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mesenchymal transition (EMT) state and loss of organoid 3-D architecture (Bates and 
Mercurio, 2003; Hahn et al., 2017; Onozato et al., 2018; Wendt et al., 2011). These data 
demonstrate that both small intestinal and colonic organoids from Lingo3 KO and Tff2 KO 
mice have a dysregulation in organoid budding and growth. 
Therapeutic TFF2 administration promotes tissue recovery through LINGO3 
 Lastly, to establish whether TFF2 would heal damaged colonic mucosa in a manner 
dependent upon LINGO3, we asked whether therapeutic administration of the TFF2-Fc 
fusion protein would show any protective efficacy in DSS-treated WT and Lingo3 KO 
mice. Cohorts of each strain were i.p administered 150 ng of TFF2-Fc or Fc alone on days 
3, 6, and 9 following 2.5% DSS administration (Fig.2.10h). In WT DSS-treated mice, 
TFF2-Fc accelerated weight recovery, reduced DAI scores and increased colon length 
compared to Fc alone treatment, but none of these parameters were different between 
TFF2-Fc vs. Fc alone-treated Lingo3 KO mice (Fig. 2.12a-c). Histological evaluation of 
colon tissue at day 10 post-DSS administration revealed that TFF2-Fc treated WT mice 
displayed goblet cell-rich, crypt architecture, reduced immune cell infiltration and reduced 
ulcerative foci compared to WT-Fc, Lingo3 KO-TFF2-Fc or Lingo3 KO-Fc groups (Fig. 
2.12d-g). 
 Lastly, we used immunohistochemistry to determine which, if any of the known 
target proteins for TFF2-mediated signaling events were LINGO3 dependent. Since TFF2 
induces MAPK signaling (Dubeykovskaya et al., 2009; Engevik et al., 2019; Orime et al., 
2013), we first assessed anti-pERK1/2 mAb staining in colon biopsies. TFF2-Fc treatment 
significantly increased the numbers of pERK1/2 positive cells in DSS-treated colitic WT 
mice. This response was blunted in Lingo3 KO mice treated with TFF2-Fc compared to 
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their matched Fc alone controls (Fig. 2.12f-h). Second, phosphorylated STAT3 (p-STAT3) 
levels were evaluated due to its role in TFF signaling (Le et al., 2016; Pickert et al., 2009; 
Wu et al., 2016). WT mice treated with TFF2-Fc had statistically significantly decreased 
p-STAT3 levels compared to WT-Fc treated mice within intestinal epithelial cells. 
However, TFF2-Fc treatment did not change p-STAT3 levels in Lingo3 KO mice (Fig 
2.13a-b). Interestingly, Lingo3 KO mice had significantly fewer p-STAT3+ IEC cells 
compared to WT Fc-treated animals (Fig. 2.13a-b). Third, evaluation of another TFF target 
protein, b-catenin, showed TFF2-Fc caused a statistically significant decrease in b -catenin 
staining compared to WT-Fc and both Lingo3 KO groups, but TFF2 did not seem to have 
an effect in Lingo3 KO mice (Fig. 2.13c-d). Consistent with this, staining for the S-phase 
protein Ki-67 was also reduced by TFF2 treatment in a LINGO3-dependent manner (Fig 
2.13e-f). Lastly, we used cleaved caspase 3 immunostaining to evaluate apoptotic cell 
frequency among these groups. Data show TFF2 treatment did not change the number of 
cleaved caspase 3+ cells in WT mice, but there was more cleaved caspase 3+ cells in Lingo3 
KO tissues as compared to WT groups (Fig. 2.13g-h). Taken together, these data 
demonstrate that TFF2 accelerated colonic tissue recovery and this was associated with 
LINGO3 dependent MAPK activation, but LINGO3 dependent decrease in STAT3 and - 
catenin activation was TFF2 independent. Lingo3 deficiency increased IEC apoptosis 
irrespective of TFF2 treatment. 
DISCUSSION 
 Our study provides evidence that the transmembrane protein LINGO3 serves a 
critical role in IEC biology under homeostatic conditions and promotes repair during DSS-
induced colitis. IEC selectively express LINGO3 in the vicinity of TFF2-expressing goblet 
45  
cells and therapeutic administration of TFF2 heals the damaged colonic mucosa in a 
mechanism dependent upon LINGO3. This finding is significant because it is the first 
demonstration of a critical protein that functions downstream of TFF2, the latter of which 
is known to promote epithelial cell proliferation, survival, and restitution at mucosal barrier 
sites including the ocular, GI and respiratory tract (Hoffmann, 2005; Hung et al., 2018; 
Judd et al., 2015; Kurt-Jones et al., 2007; Wills-Karp et al., 2012;   Xue et al.,  2010). 
LINGO3 has no other known function(s) reported to date, therefore  our data provide a new 
avenue for understanding how TFF2 mediates  wound  healing and epithelial cell barrier 
function at the mucosal interface. In human tissues, LINGO3 was constitutively expressed 
on mucosal epithelia lining the sigmoid colon and turbinate sinuses of the upper airway. In 
mice, loss of function studies revealed basally increased inflammation, defective 
expression of the cell adhesion molecule E-cadherin and defects in colonic tissue 
regeneration post-acute tissue injury caused during DSS-colitis. Because the ability of 
TFF2 to modulate the abundance of signal transduction proteins was only partially 
LINGO3-dependent, it is likely that there are one or more receptor components necessary 
for TFF2 responsiveness that remain un-identified. 
 Pursuit of novel candidate TFF receptor(s) led us to employ TRICEPs technology 
created for identification of low-affinity protein interactions with glycosylated cell- surface 
receptors (Frei et al., 2012; Frei et al., 2013). That initiative led us to investigate LINGO3. 
LINGO3 is a 166 AA single pass transmembrane protein with 11 leucine repeats, 8 N-
linked glycosylation sites, a single disulfide bond, and a short cytoplasmic tail containing 
2 serine’s and a single tyrosine (https://www.uniprot.org/uniprot/ Q6GQU6). Although 
several reports have suggested that CXCR4, serves as a  low affinity receptor for TFF2 
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(Dubeykovskaya et al., 2009), those  studies  largely  rely  upon the CXCR4 antagonist 
AMD3100. There are no data that  have  demonstrated  direct binding between TFF2 and 
CXCR4, CXCR4-dependent TFF2 signaling in vivo, or that Cxcr4 deficient mice 
phenocopy any aspect of Tff2 deficiency such as impaired barrier integrity, basal Type 1 
inflammation, or defects in the gastric compartment (Farrell et al., 2002; McBerry et al., 
2012). Although TFF2-LINGO3 only weakly interact as determined by flow cytometry 
and immunoprecipitation assays, the Lingo3 KO mice that we generated clearly indicate 
defects in IEC-expression of E- cadherin, basal endotoxemia, enhanced mucosal Type 1 
inflammation, and disease exacerbation  during  DSS-colitis.  Strikingly,  these  are   the 
reported features of Tff2 KO mice (Judd et al., 2015; McBerry et al., 2012). Further, TFF2-
mediated healing following DSS including weight recovery and ERK1/2 activation were 
LINGO3 dependent.  However, Lingo3 deficiency on its own resulted in other deficiencies 
such as STAT3 activation and the number of IEC actively in S-phase during the wound 
healing phase post-DSS colitis. Decreased p-STAT3 is consistent with our finding that 
TFF2-Fc treatment decreases inflammation in WT DSS mice. Interestingly, both ERK1/2 
and JAK/STAT3 signaling have been implicated in downstream of Trefoil signaling 
(Dubeykovskaya et al., 2009; Engevik et al., 2019; Orime et al., 2013). While we cannot 
rule out the possibility that TFF2 responsiveness additionally involves CXCR4 (or other 
transmembrane signaling proteins), these data show that LINGO3 serves multiple roles 
within the GI tract during homeostasis and tissue repair. 
 Tight junction complexes between epithelial cells at mucosal interfaces regulate 
paracellular permeability (Campbell et al., 2017). EM photomicrographs show a striking 
abnormal architecture in the Lingo3 KO IEC adherens junctional space, a region primarily 
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comprised of E-cadherin-CD103 complexes (Campbell et al., 2017). Indeed, reduced Cdh1 
and Itgae mRNA transcript levels as well as reduced protein levels of E-cadherin in Lingo3 
KO mice suggest that these genes require LINGO3 activity through unknown mechanisms. 
TFF2 administration did not induce Cdh1 or Itgae expression (data not shown), thus it is 
likely that LINGO3 acts with other components to facilitate TFF2 responsiveness 
biologically similar to LINGO1 signaling requirements that involve a tri-molecular 
complex including TNFSF19/TROY and nogo-66 receptor/nogo receptor 1 (NgR) (Saha 
et al., 2014; Satoh et al., 2007). LINGO1 is similar in structure to LGR4, a leucine rich 
repeat type 2 family receptor, which binds to R-spondin and signals through WNT proteins, 
a necessary signaling pathway for maintenance of intestinal stem cells (Xu et al., 2013). 
Given the amino acid sequence homology between LINGO3 and LGR4, it is possible that 
LGR4 may also be a component of the TFF2-LINGO3 signaling pathway. In fact, the 
defective expression of Lgr5, coincident with the marked dysregulation of intestinal 
organoid growth and delayed restoration of goblet cell expansion post-DSS mediated 
injury, make it tempting to speculate that LINGO3 is somehow involved in regulation of 
intestinal stem cell activity. 
 Although, we were unable to directly detect mouse LINGO3 in gut tissues due to 
the lack of validated anti-mouse LINGO3 Ab, we did note that human LINGO3 
immunostaining localized to enterocytes and cells within the crypt base where ISC 
progenitors are found including Lgr5+ cells (Koo and Clevers, 2014; Sato et al., 2009). 
Following crypt irradiation, Lgr5+ stem cells respond to intestinal damage by repopulating 
the intestine (Andersson-Rolf et al., 2017; Chang et al., 2016; Koo and Clevers, 2014). 
TFF2 administration promoted growth of gastric organoids through EGFR signaling 
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(Engevik et al., 2019) making it possible that the defects observed in Tff2-and Lingo3 
deficient intestinal organoids were somehow due to impaired EGFR activation. 
Alternatively, tight junction complexes are necessary for crypt formation therefore it is also 
possible that the defect in E-cadherin-CD103 complexes observed in Lingo3 KO and Tff2 
KO organoids was responsible for the EMT phenotype resulting in the spontaneous 
transition from 3D to 2D architecture (Onozato et al., 2018; Sato and Clevers, 2013). 
Defects in EMT are linked to cancer metastasis (Wendt et al., 2011). Given the defect in 
E-cadherin-CD103 complexes, the transition of Lingo3 KO and Tff2 KO organoids from 
3D to 2D, and the increased inflammation in naïve Lingo3 KO and Tff2 KO mice implicates 
a potential role of Lingo3-TFF2 colitis associated cancers and metastasis. This is further 
supported by previous reports which have demonstrated that TFF2 could be a putative 
colorectal cancer treatment (Dubeykovskaya et al., 2019). 
 Overall, this is the first report, to our knowledge demonstrating that the orphan 
transmembrane type 1 receptor LINGO3, serves a critical role in GI homeostasis and 
wound healing following DSS-mediated colitis. LINGO3 partially controls TFF2 
responsiveness for MAPK signaling and mucosal tissue repair, and clearly deserves further 
investigation as a potential therapeutic target in human patients with various forms of 
inflammatory bowel disease. 
Methods 
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 Mice. All animal procedures were approved by the Institutional Animal Care and 
Use Committee at University of California, San Francisco. WT and Tff2 KO C57BL6 mice 
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were bred in house. Super-ovulated female C57BL/6 mice (4 weeks old) were mated to 
C57BL/6 stud males. Fertilized zygotes were collected from oviducts and injected with 
Cas9 protein (30 ng/ul), sgRNA (15 ng/ul) into pronucleus of fertilized zygotes. Injected 
zygotes were implanted into oviducts of pseudo pregnant CD1 female mice. Animals were 
housed under specific-pathogen free barriers in vivarium at San Francisco General Hospital 
or University of Pennsylvania. All procedures were reviewed and approved by IACUC at 
University of California at San Francisco (protocol #AN109782-01) and University of 
Pennsylvania (protocol #805911). 
 Single Nucleotide Polymorphism (SNP) analysis: SNP analysis was performed 
using DARTmouse. Tails were cut from Lingo3 KO mice (1 male breeder, 1 female 
breeder, 1 male pup, and 1 female pup) and sent to DARTmouse which performed analysis 
on 5307 SNPs across all chromosomes in C57BL/6 WT mice and provided Lingo3 KO 
mice. 
 Dextran sodium sulfate (DSS) model. All experiments used six to ten-week-old 
wildtype (WT) or Lingo3 KO C57BL/6 female mice bred in house and cohoused for four 
weeks. Colitis was induced using 2.5% Dextran Sulfate Sodium Salt (w/v, 0216011080, 
MP-Biomedicals LLC Solon, OH) in autoclaved drinking water for 6 days. Fresh solution 
was provided on day 3, on day 6 mice were returned to normal water and monitored until 
necropsy. For TFF2 treatment, mice were administered either 150 ng of TFF2-Fc (1ng/µL) 
or Fc (1 ng/µL) via intraperitoneal injection on Day 3, 6, 9 post 2.5% DSS treatment. Body 
weight, appearance, fecal occult blood (Fisherbrand™ Sure-Vue™ Fecal Occult Blood 
Slide Test System, ThermoFisher Scientific, Inc., Waltham, MA, USA), stool consistency, 
and diarrhea were recorded daily from tattooed animals. Colon length was determined at 
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necropsy. Disease activity index (DAI) a cumulative score with a maximum of 12, was 
derived as follows: every mouse was assigned a score of 1 Vs 0 for each display of lack of 
grooming, piloerection, awkward gait, hunched posture, and lack of mobility. Diarrhea 
score (0 Normal stool, 1 soft stool, 2 loose formed stools, and 3 watery fecal matter), Rectal 
Bleeding was scored as 0 no blood, 1 minor bleeding, and 2 gross rectal bleeding). Fecal 
occult blood test was scored as 0 Negative, 1 Mild amount of blood, and 2 excessive 
presence of blood. H&E were evaluated by a clinical pathologist at the veterinary 
comparative pathothology core at the University of Pennsylvania following DSS 
administration and following DSS administration +/- TFF2-Fc or Fc treatment. 
Histopathological analysis has been focused on assessing the chronic mucosal changes 
(inflammatory and proliferative) of the mid and distal colorectal tract present in each 
sample. In some samples, the pathological picture was very heterogeneous combining 
severe ulcerative lesions with nearly normal mucosal segments. This finding reflects the 
typical multifocal nature of the ulcerative and inflammatory lesions induced by repeated 
DSS administration. The extensive loss of mucosal glands observed in some of the samples 
precluded in part the evaluation of pathological changes specifically affecting the mucosal 
crypts including inflammation and hyperplasia. pERK1/2 (CST #4370), Caspase-3 (CST 
#9661), p-STAT3 (CST #9145S), b-catenin (CST #9582), and Ki-67 (Thermo Scientific 
RM-9106-S) immunohistochemistry staining was performed by the comparative pathology 
core at the University of Pennsylvania. For quantification of b-catenin the region of interest 
was outlined and % Threshold area was measured using MetaMorph microscopy 
automation and image analysis software. All images were normalized using a standard set 
for hue, saturation, and intensity (72,255,255, respectively). 
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 Co-immunoprecipitation. 2.4 × 106 CHO cells were transfected with 24  g 
pCMV6:Lingo3: Flag (MR209193, Origene) or pCMV6 entry plasmids. After incubation 
of the transfection mixture with the cells for 60 h, the cells were washed twice with PBS 
and lysed with 300 µL digitonin extraction buffer [1% digitonin; 150 mM NaCl; 1 mM 
MgCl2; 10 mM TrisHCl, pH 7.4, 1X Proteinase Inhibitor (Pierce), 1mM PMSF]. The 
protein concentration was measured using BCA assay kit (Invitrogen). Around 0.6 mg total 
protein was mixed with 20 µg purified TFF2-Fc (Ray Biotech) or Fc (Ray Biotech) and 
precleared with control agarose resin for 1 hr at 4°C. The lysate samples were then 
precipitated with 40 µl protein A/G agarose (Invitrogen) overnight at 4°C. The 
immunoprecipitation (IP) complex was washed with TBS for 5 times and eluted with 4× 
SDS loading buffer at 95°C. The IP elutes along with whole cell lysates were 
immunoblotted with rabbit anti-FLAG (1:400) followed by incubation with goat anti-rabbit 
IgG Cy5 (1:1000). TFF2-Fc and Fc were generated by transfecting HEK293 cells (500 mL) 
with MaxiPrep extracted plasmid DNA. After 3 days post transfection, the cell culture 
medium was collected for protein G affinity purification. 
 Human tissue and immunostaining. Archived rectosigmoid biopsy samples were 
from the SCOPE cohort at the University of California, San Francisco (UCSF). The UCSF 
Committee on Human Research reviewed and approved the SCOPE study (IRB# 10- 
01218), all participants provided written informed consent. Using this cohort, archived gut 
biopsies and plasma samples were selected from HIV-negative participants. Prior to 
sigmoidoscopy and gastrointestinal biopsy, study participants underwent a blood draw and 
received a Fleet enema. Rectosigmoid biopsies were obtained by sigmoidoscopy 10-30 cm 
from the anal verge. Human sinonasal polyp samples were obtained from patients 
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undergoing sinonasal surgery for the management of their chronic rhinosinusitis with 
informed consent and full approval of the University of Pennsylvania Institutional Review 
Board (Protocol #800614). Tissue sections from Human sinonasal polyps and Human 
Rectosigmoid (normal) were fixed in formalin and paraffin embedded. The sections were 
then deparaffinized and antigen was retrieved using an electric pressure cooker (Nesco 
PC6-25P) in a low-pH Citrate Buffer. The slides were then incubated and stained with the 
following primary Antibodies: anti-LINGO3 Ab was raised against Goat (Santa Cruz sc- 
247444) and anti-TFF2 raised against Rabbit (Peprotech: 500-P312) were used to detect 
the LINGO3 and TFF2 interactions in situ. Primary antibodies were then followed by 
incubation with the Alexa Fluor series of secondary antibodies (AffiniPure F(ab')₂ 
Fragment Donkey Anti-Mouse IgG, AffiniPure F(ab')₂ Fragment Donkey Anti-Rabbit IgG, 
AffiniPure F(ab')₂ Fragment Donkey Anti-Goat IgG) supplied by Jackson 
ImmunoResearch. Detection of fluorescence was observed under Cy2, Cy3, and Cy5 filters 
on a Leica Inverted Microscope DMi8 S Platform and a Leica DM6000B microscope with 
an automated stage coupled with a Leica DFC350FX camera. We normalized exposure 
times and fluorescence intensities to appropriate control images. We photographed 
fluorescent channels separately, merged them together and overlaid them atop the 
corresponding images. 
 Western Blotting. Distal colon tissue was isolated from WT and Lingo3 KO 
C57BL6 mice and lysed in Schlessing buffer (50 mM HEPES, 50 mM NaCl, 10% glycerol, 
1% Triton X-100, 1mM EDTA, 10 nM sodium pyrophosphate, Roche proteinase inhibitor 
(1 tablet in 7mL buffer), Roche phosphatase inhibitor (1:1000 dilution). Tissue was 
homogenized and centrifuged at full speed for 5 minutes, lysates were collected. Protein 
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concentration was measured using Pierce BCA protein Assay Kit (ThermoFisher #23225) 
and absorbance was read at 562 nm using Synergy 2 microplate reader and the Gen 5.0 
Software (BioTek). 10µg of protein lysates + 5µL of 5X protein sample buffer (125 mM 
Tris, pH6.8, 10% SDS, 50% Glycerol, Water, 0.06% Bromophenol blue, 1% b- 
mercaptoethanol) + H20, for a final volume of 25µl was added to a Nupage 4-12% bis-tris 
PAGE protein gel. The gel was run for 40 minutes at 200v in 1X Nupage MOPS SDS 
running buffer. The gel was then transferred using a PVDF membrane and Transfer buffer 
(2.42 g Tris Base, 10.80 g Glycine, 100 mL Methanol, 900 mL Deionized H20) for 1 hour 
and 10 minutes at 30v. Post transfer, membranes were blocked using 5% TBS-T for 1 hour. 
Primary antibodies were stained overnight at 4C. E-cadherin (ebioscience #14-324982) 
was used at a 1:250 dilution and  -actin (Santa Cruz 47778) was used at a 1:2000 dilution. 
The following day membranes were washed 3X in TBST for 5 minutes and then stained 
with secondary antibodies (a-rat IgG 1:2000 (Jackson Immunoresearch #112-036-068), 
and (a-mouse IgG 1:2000 (CST #7076s)). Pierce ECL western blotting substrate 
(ThermoFisher #32106) was used to develop the membranes. Image Lab Software 6.0.1 
was used to take a picture of the membranes. 
Soluble ligand binding assay. Purified murine IgG (Ray Biotech), murine recombinant 
TFF2 (Peprotech) and SDF1a (R&D systems) were labeled with Alexa Fluor 647 dye using 
the Alexa Fluor 647 protein labeling kit (A30009, Molecular Probes) per manufacturer’s 
directions. HEK293 cells were maintained in DMEM medium (Invitrogen) supplemented 
with 10% fetal bovine serum (Invitrogen) and 1% penicillin- streptomycin (Invitrogen) at 
37ºC with 5% CO2. HEK293 cells were seeded at 1 x 106/well and incubated at 37ºC with 
5% CO2 overnight before transfection with 3ug of plasmids pCMV3-mLINGO3-GFP, 
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pCMV3-mLINGO2-GFP or 6ug of pCMV3- mCXCR4-GFP using FuGENE HD DNA 
transfection reagent (Promega) based on manufacturer’s instructions. 24h post transfection, 
cells were incubated with either PBS or 3µg of Alexa Fluor 647 labeled soluble ligands for 
3h at 4ºC. Cells expressing GFP and Alexa Fluor 647 positive were identified by flow 
cytometry. 
 Transmission electron microscopy. 2-mm length mouse distal colon and jejunum 
was dissected and immersed in the primary fixative buffer (2% Paraformaldehyde, 2.5% 
Glutaraldehyde, and 0.05% Ruthenium Red in a 0.2M Cacodylate Buffer) overnight at 4 
°C and then washed with 0.1M Cacodylate Buffer. Then, the sample was post fixed with 
2% aqueous OsO4, 0.05% Ruthenium Red in 0.2 M Cacodylate Buffer for 2 hours and 
washed 0.1 M Cacodylate Buffer wash. The sample was dehydrated with 50%, 70%, 80%, 
90%, 95% and 100% ethanol sequentially. After that, the sample was embedded with Epon 
812 and cured for 48 hours in a 60°C oven. 
Finally, ultra-thin sections (~70nm) of the sample was taken and stained with uranyl acetate 
for 4 min and lead citrate for 2 min. The sample was studied by using JEOL USA 
Transmission Electron Microscope. 
 16S rRNA gene sequencing. Genomic DNA was extracted from fecal pellets of 
mice using Qiagen DNeasy PowerSoil Kit. The V4 region of the 16S rRNA gene was 
amplified using barcoded primers for use on the Illumina platform (Jasarevic et al., 2018; 
Kozich et al., 2013). Sequencing was performed using 250-base paired-end chemistry on 
an Illumina MiSeq instrument. QIIME v. 1.8 (Caporaso et al., 2010) was used to process 
paired-end reads and to perform downstream analyses including taxonomy assignment and 
heat map generation. 
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 Histological staining. Colon tissue was either opened longitudinally, flushed with 
ice-cold PBS to remove feces and formalin fixed as “swiss rolls” or 1-2 cm of the distal 
colon. Colon tissues were stained with hematoxylin and eosin (H&E), periodic acid Schiff 
stain (PAS). 1-2 cm of Jejunum tissue was formalin fixed. Jejunum was stained with PAS. 
A Leica widefield microscope was used for imaging. A clinical pathologist evaluated H&E 
colon slides. 
 Quantitative RT-PCR. For intestinal epithelial cell isolation, colons and small 
intestines were dissected from WT and Lingo3 KO mice and cut open longitudinally. 
Intestines were washed 3X in Hank’s Buffered Saline Solution (HBSS) containing 5mM 
EDTA+ 2.5mM DTT for 10 mins shaking at 37C. Following 10min incubation intestines 
were vigorously shaken by hand using forceps, epithelial cell fraction was collected. 
Following 3X washes epithelial fractions were spun down at 1500 RPM for 5 min, and 
supernatants were aspirated. Cell pellets were then resuspended in 10 mL HBSS and 
filtered through a 70 micron strainer and centrifuged for 5 minutes at 1500 RPM. Cells 
pellets were resuspended in 1 mL HBSS and filtered through a 40 micron strainer 
centrifuged at 1500 RPM for 10 mins. For CD4+ cells, B220+ cells, CD11b+CD11c+ cell 
isolation spleens and MLN were pooled and homogenized from WT and Lingo3 KO mice. 
Cells were positively selected for CD4, B220, or a pool of CD11b/CD11c using 
Microbeads sorts (Miltenyi Biotec #130-108-338, 130-049-601, 130-049-201, 130-049- 
501). For bone marrow isolation, isolated femurs from WT and Lingo3 KO mice were 
crushed using mortar and pestle and passed through a cellular strainer to separate cells from 
bone and muscle debris. Cells were then centrifuged at 2000 rpm for 5 min. at 4C. 
Supernatant was removed, and cells were resuspended in 7 mL of DMEM media and 
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layered on top of Histopaque. Cells were then centrifuged at 2000 RPM for 20 min. at low 
breaking. Following centrifugation, the cell layer was collected and resuspended in equal 
volume of media and centrifuged at 1500 RPM for 5 min. Following centrifugation RNA 
was purified from cell subsets. RNA was purified from cell subsets (intestinal epithelial 
cells, CD4+ cells, B220+ cells, CD11b+ cells), whole colon ileum, lung, bone marrow, 
spleen , liver, heart, kidney, and brain, homogenized tissue, or organoid cultures (at day 7 
of culture) using nucleospin RNA plus kit (clontech # 740984.25). cDNA was prepared 
using 1µL of 100 ng Random primers (Invitrogen), 1 µg of RNA, 10 mM dNTP 
(Invitrogen), and 1 µL of Maxima H Reverse Transcriptase (ThermoFisher #EP0752). 
PCRs were set up in a final volume of 20 µL using 2uL DNA, 1 µL 20 µM Forward and 
reverse primer, and 2X Sybr Green I Master Mix (Bio-Rad #172-5274). Gene expression 
was measured using Bio-Rad CFX machine and data normalized to GAPDH and presented 
as MEAN ± SEM from the replicates. For the TaqMan hybridization assays 4 µL of 300 
ng cDNA was added to a master mix containing to 10 µL 2X TaqMan gene expression 
master mix (Thermofisher catalog #4369016), 5µL RNase free water, and 1 µL of Lingo3 
TaqMan MGB 20x probe (ThermoFisher #Mm01178145) or 1 µL of HPRT TaqMan MGB 
20x probe (ThermoFisher #Mm00446968), for a final volume of 20 µL. Data was 
normalized to HPRT. For the SYBR green assays 2µL of 300 ng cDNA was added to a 
master mix containing of 10 µL SYBR green assays SsoAdvanced SYBR Green (Bio-Rad 
#172-5274), 1µL Lingo3 forward primer (5’ GCA CTT GCT GCT GCT GCC 3’), 1µL 
Lingo3 Reverse primer (5’ CTC GGG GAT GGC TGT CAG 3’), 6µL RNase Free water, 
for a final volume of 20 µL. Data was normalized to GAPDH. All real-time PCR reactions 
were carried out on Bio-Rad CFX96 system and data were analyzed using the ΔΔCt method 
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as recommended in the manual. 
 Flow Cytometry. MLN was dissected from WT and Lingo3 KO mice, 
homogenized, and resuspended in 1mL of RPMI. A 5 cm portion of colon was washed 
three times for 10 minutes each at 37°C in 5mM EDTA+ 2.5mM DTT for removal of 
epithelial cells and mucus. In between every wash colons were washed with HBSS 
containing 25mM HEPES and 2% FCS. Following epithelial and mucus removal, 
intestines were minced and incubated at 37°C for 25 minutes in 7mL digestion buffer 
(DMEM+2%FBS +0.05mg/mL Liberase TM +0.02 mg/mL DNase (Sigma #5401127001, 
#11284932001, respectively). Post-incubation tissues were extruded through a 16-gauge 
needle 10 times, further 3 mL of fresh digestion buffer was added to the digested tissue 
suspension and incubated for another 20 minutes at 37°C. Post-incubation, tissues were 
extruded through an 18-gauge needle ten times. 10 mL of digested tissue was spun down 
1600 RPM with low brake for 7 minutes. Supernatant was removed, cells were resuspended 
in 5 mL of RPMI containing 10% FBS (cRPMI) and filtered through a 40-micron strainer. 
Cells were re-centrifuged at 1600 RPM for 7 minutes. Supernatant was removed and cells 
were resuspended in 1 mL of cRPMI. Cell concentration was determined using the Muse 
cell counter (EMD Millipore). For intracellular cytokine staining mesenteric lymph node 
(MLN) cells and Lamina propria cells were stimulated (Stim) in RPMI containing 
100ng/mL PMA + 1µg/mL ionomycin + 10 µg/mL brefeldin A (BFA) + monesin (1:1500 
dilution) or media (Med) containing 10 µg/mL brefeldin A (BFA) + monesin (1:1500 
dilution) for four hours at 37°C. Following stimulation cells were washed in PBS and 
stained with the following surface markers: LiveDead Aqua CD4 APC-cy7 (Clone Gk1.5, 
Biolegend #100414), CD8 PE-TexasRed (clone 5H10 ThermoFisher#MCD0817), CD44 
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AF700 (clone IM7, Thermofisher 56044182) , CD62L PE-cy5 (clone MEL-14, Biolegend 
104418), CD19 FITC (clone MB19-1, Thermofisher 11-0191-85), CD11b FITC (clone 
M1/70,Biolegend 101206) CD11c FITC(clone N418, Thermofisher 11-0114-85, diluted in 
Fc block. After surface stain, cells were washed with FACs buffer and fixed for 20 minutes. 
Post fixation cells were washed with permeabilization buffer and stained overnight with 
the following markers: TNF APC (Clone MP6-XT22, ThermoFisher 17- 7321-81), IFNg 
PE (clone XMG1.2, Biolegend 505808). For the myeloid flow cytometry panel the 
following surface markers were used: LiveDead Aqua, CD11c PE-Texas Red (Clone N418, 
Thermofisher MCD11c17), CD103 BV605 (Clone 2E7, Biolegend 121433), CD64 PE/Cy7 
(clone Fc RI, Biolegend 139314), Ly6c APC-Cy7 (CloneHK1.4, Biolegend #128026), 
MHCII AF700 (Clone M5/114.15.2, Biolegend #107622), CX3CR1 BV785 (Clone 
SA011F11, Biolegend #149029), XCR1 BV650 (clone ZET, Biolegend #148225), SIRPa 
PerCP-Cy5.5 (Clone P84, Biolegend #144010), NK1.1 FITC (Clone PK136, Biolegend 
#108706), CD3 FITC (Clone 17A2, Biolegend #100204), CD19 FITC(Clone MB19-1, 
ThermoFisher #11-0191-82) 
 Evaluation of intestinal permeability. WT and Lingo3 KO C57BL6 cohoused (4 
weeks) mice were fasted for 16 hours and orally gavaged with 200 µL of 44mg/100g of 
4kDA fluorescein isothiocyanate dextran (FITC-dextran) (Sigma, FD4). 4hrs post 
administration, mice were euthanized, and blood was collected. A standard curve was 
generated from 0.1-1 mg/mL of FITC-dextran and fluorescence was measured at a 
wavelength of 520 nm using Synergy 2 microplate reader and the Gen 5.0 software 
(BioTek). Limulus Amebocyte Lysate (LAL) assay was performed on serum from WT and 
Lingo3 KO C57BL6 cohoused (4 weeks) mice using Pierce LAL chromogenic endotoxin 
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quantification kit (ThermoFisher #88282). Endotoxin levels was measured using 
absorbance at 405-410 nm using Synergy 2 microplate reader and the Gen 5.0 Software 
(BioTek). 
 Nasal ALI and intestinal organoid cultures. Primary murine nasal epithelial cells 
were grown for 7 days as submerged cultures and for 2 weeks at air liquid interface in trans 
wells. On day 21, monolayers were wounded in a cross pattern with a sterile pipet tip (1mm 
width) and treated daily on the apical side with 10 ng/ml recombinant human TFF2 
(Peprotech) or 1xPBS (Mock). Cultures were rinsed with 1X PBS prior to TEER 
measurement. Serial measurements of TEER (Ohms-cm2) were taken using an EVOM 
(World precision instruments) and the cup/trans well insert adapter. Crypts were isolated 
from mouse small intestinal jejunum with modifications indicated (Mahe et al., 2013; Sato 
et al., 2009). Briefly, the small intestines and colons of WT and Lingo3 KO mice were 
removed, opened longitudinally and washed with Ca2+-Mg2+-free Hank’s balanced salt 
solution (HBSS). Villi were scraped off using a coverslip under a dissecting microscope 
then tissue incubated in 5mM EDTA in HBSS for 30 mins at 4ºC on an orbital shaker. 
Residual villi were removed with further washing. The crypts were separated from the 
basal membrane by vigorous pipetting in 0.5% BSA in HBSS and then filtered through a 
70-µm cell strainer. Crypts were pelleted at 250 x g (5 min, 4ºC) and resuspended in 
complete crypt culture medium (Advanced DMEM/F12 [Thermo, 12634-010], 10 mM 
HEPES [IVT, 15630-080], 1x penicillin/streptomycin [IVT, 15140-122], 1x gentamycin 
[Gibco, 15750-500], 1x N2 Supplement [IVT, 17502-048] , 1x B27 Supplement [IVT 
17504-044], 1mM N-Acetyl-cysteine [Sigma, A9165-5g], 50ng/mL recombinant mouse 
epidermal grown factor [IVT, PMG8041], 100ng/mL mNOGGIN [peprotech, 250-38], 
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1µg/mL R-spondin 1 [R&D, 3474-RS-050], 5mM CHIR99021 [Stemgent 04-0004], to a 
final volume of 2%). Approximately 100-300 crypts per well were then embedded in 80% 
Matrigel/20% complete crypt culture media in pre-warmed 48-well flat bottom plates and 
incubated for 15 min at 37ºC. Embedded enteroids were cultured in 200 µL of complete 
crypt culture media added at 37ºC and 5% CO2 with media changed every 2-3 days. 
Organoids were imaged using an inverted Nikon eclipse (TE2000-U) widefield microscope 
at 4x, 10x, and 20 x on day 3, 5, and 7 of growth. 
 Statistics. Statistical analyses were performed using GraphPad Prism version 7.0 
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 Fig 2.1 LINGO3 is an orphan leucine rich repeat and Ig domain containing 
receptor expressed on mucosal epithelia of mice and humans. (a) Cartoon 
image of LINGO3 protein (b) Lingo3 mRNA expression in mucosal tissues at the 
steady-state (c) Lingo3 expression in small and large intestinal epithelial cells (IECs) 
fraction, or mesenteric and splenic CD4+, B220+, CD11b+ CD11c+ cells (d-i) 
Double immunofluorescence staining using anti-TFF2Ab (red) and anti-LINGO3 Ab 
(green) vs. isotype matched Ab on  human rectum (Magnification 32x, 32x with 
digital zoom, respectively) (j-n) and human nasal polyps (Magnification 20x, 20x 
with digital zoom, respectively). Red arrows depict Lingo3 expression on apical side 
of the tissue while yellow depict Lingo3 expression at the base of intestinal crypts. 
Mean ± SEM from n=4-6 samples shown. Mice were cohoused, female 2months old 
























Fig 2.2 Single Nucleotide Polymorphism (SNP) are normal in Lingo3 KO mice. 
5307 SNPs were analyzed across all chromosomes. (a) SNPs found in WT C57Bl/6 
mouse (b) SNPs analyzed in Lingo3 KO male breeder (c) SNPs analyzed in Lingo3 KO 
female breeder (d) SNPs analyzed in Lingo3 KO male pup (e) SNPs analyzed in Lingo3 
KO female pup (f) Lingo3 mRNA levels in liver, kidney, bone marrow (BM), spleen, brain, 
and heart. For all SNP analysis one Lingo3 KO mouse was used per SNP analysis, all 
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 Fig 2.3 LINGO3 and TFF2 do not directly bind. (a) Gating strategy for HEK transfected cells 
incubated with protein (b) HEK 293 binding controls percent of doubly fluorescent cells identified in the
 upper right quadrant for Lingo3-GFP transfectants incubated with (c) IgG-647 (d) TFF2-647 (e) Lingo2-GFP 
transfected HEK cells incubated with TFF2-647 (f) CXCR4-GFP transfectants incubated with TFF2-647 
(g) CXCR4-GFP transfectants incubated with SDF1-647 (h) 12% SDS-PAGE gel analysis of affinity purifed 
recombinant IgG2bFc-His and TFF2/IgG2bFc-Hisb(i) Coimmunnoprecipitation of Flag-Lingo3 and TFF2-Fc in 
transfected CHO cells (j) Control TFF2-Fc and Fc without co-immunoprecipitation migrate at 50 kD and 40 kD 
(k) Transepithelial resistance (TEER) of primary WT and Lingo3KO nasal epithelia following rTFF2(10ȝg/mL)
 or 1x PBS treatment. Mean ± SEM from 4-5 samples shown, mice used in (k) were cohoused. 
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 Fig. 2.4 Lingo3 deficient mice show basal defects in mucosal barrier function and 
enhanced myeloid and lymphoid inflammatory responses at the steady-state. (a) 
FITC-Dextran concentration (+g/mL) in serum at 4h post oral gavage (b) Photomicro-
graphs of PAS-stained colon tissues from naïve  WT and Lingo3 KO mice (Magnification 
17x) (c) Frequency of DCs in MLN (d) Number of DCs in MLN (e) Frequency of 
CD103+XCR1+ DCs in MLN (f) Number of CD103+XCR1+ DCs in MLN (g) Frequency of 
XCR1+CD103- DCs in MLN (h)Number of XCR1+CD103- DCs in MLN (i) Frequency of 
SIRP_+ DCs in MLN (j) Number of SIRP_+ DCs in MLN (k) IFNa CD4+ cells in MLN (l) 
IFNa+ central memory phenotype CD4+ cell frequencies in MLN (m) Mean fluorescence 
intensity for IFNa in central memory phenotype CD4+ cells from MLN (n) IFNaHiTNFHI 
CD4+ frequencies in colon. Med refers to media only conditions containing 10 +g/mL 
Brefeldin A + Monesin (1:1500) while Stim refers a 4 hour stimulation with media contain-
ing 1+g/mL PMA + 100 ng/mL ionomycin +10 +g/mL Brefeldin A + Monesin (1:1500). 


































































































































Fig. 2.7 Lingo3 deficiency disrupts IEC adherens junctional complexes and abrogates 
E-cadherin protein expression within intestine. (a) TEM photomicrographs of jejunum at 
30K and 75K magnification from naïve WT and Lingo3 KO mice at the steady-state (b) TEM 
photomicrographs of colon at 30K and 75K from naïve WT and Lingo3 KO mice at steady 
state (c-d) Quantification of Cdh1 and Itgae mRNA transcripts in naïve colon tissues from WT 
and Lingo3 KO mice (e) Western blotting of E-cadherin levels in naïve colons from WT and 
Lingo3 KO mice (f) Densitometric quantification of E-cadherin to `-actin levels within each 
colon sample.  Arrows point to structures within TEM images as well as defects in adherens 
junction. Mean ± SEM from n=2-5 cohoused mice/genotype. 2-3 independent experiments. 
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Fig. 2.8 No differences in early phase DSS-induced colitis between WT and Lingo3 KO mice. (a) Percent  
change in body weight (b) Disease activity index (DAI) scores  (c) and colon length following 3 days oral administration of 
2.5% DSS (d) Percent change in body weight (e) Disease activity index (DAI) scores (f) and colon length following 6 days 
oral administration of 2.5% DSS (g) Representative H&E and PAS images (4x, 20x) in WT mice following 3 days oral 
administration of 2.5% DSS (h) Representative H&E and PAS images (4x,20x) in WT mice following 6 days oral 
administration of 2.5% DSS (i) Representative H&E and PAS images (4x,20x) in Lingo3 KO mice following 3 days oral 
administration of 2.5% DSS (j) Representative H&E and PAS images (4x,20x) in Lingo3 KO mice following 6 days oral 
administration of 2.5% DSS. Representative of one independent experiment. N=2-3 mice/genotype, cohoused, female 
2 months old.  
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Fig. 2.9 Lingo3 KO mice have enhanced disease severity during 
DSS-induced colitis. (a) Percent change in body weight and (b) disease activity 
score (DAI) over the course of 2.5% DSS-treatment (c) Colon lengths (cm) at 5 
days following cessation of DSS treatment (d) H&E stained histological sections 
of the colon (Magnification 10x) (e) PAS-stained histological sections of colon 
tissue at 5 days following DSS cessation (Magnification 10x) (f) PAS-stained 
histological sections of colon tissue 5 days following DSS cessation 





Fig. 2.10 Lingo3 KO and Tff2 KO organoids have growth and architecture defects. (a) Survival curve 
during 2.5% DSS administration in WT and Lingo3 KO mice. Survival is determined based on IACUC protocol  of a loss 
of weight >20% (b) Lgr5 mRNA expression in  colons from naive or day 10 post 2.5% DSS administration (c) Number of 
small intestinal budding organoids  per genotype at day 3 (d3) and day 5 (d5) of culture (d) Area (pixels/um) of organoids 
at d3 and d5 of culture (e) Tff3 and Tff2 mRNA expression in organoids day 7 of culture (f) Number of colonic budding 
organoids per genotype at d3 and d5 of culture (g) Number of 2D organoids (per highpowerfield) at d3 and d5 of culture 
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Fig. 2.11 Either Lingo3 or Tff2 deficiency causes defective intestinal organoid 
growth, budding and structure. (a) Photomicrograph brightfield microscopy images 
(magnification 20x) taken at days 3, 5, 7 during small intestinal organoid culture from 
WT, Lingo3 KO, Tff2 KO mouse strains. Arrows point to buds. (b) Number of budding 
organoids per genotype at day 7 of culture (c) Area (pixels/um) of organoids  at day 7 
of culture (d) Intestinal organoid Lgr5 mRNA expression at day 7 (e) Photomicrograph 
brightfield microscopy images (magnification 20x) taken at day 3,5,7 during colonic 
organoid culture from WT, Lingo3 KO, and Tff2 KO mouse strains (f) Number of bud-
ding organoids at day 7 of culture (g) Number of 2 dimensional (2d) organoids per 
































































































































Fig 2.12. TFF2 agonist treatment requires LINGO3 to accelerate weight gain and tissue heal-
ing post DSS-colitis. (a) Change in body weight (b) and disease activity following therapeutic 
administration of Fc or TFF2-Fc at the timepoints indicated following oral administration of 2.5% DSS 
(c) Colon length (cm) (d) Clinical inflammation score (e) clinical mucosal/crypt loss score (f) H&E 
and pERK1/2 stained images of colon following Fc treatment 10 days post 2.5% DSS (Magnification 
20x) (g) H&E and pERK stained images of colon following TFF2-Fc treatment 10 days post 2.5% 
DSS (Magnification 20x) (h) Quantification of pERK+ cells per high powerfield (HPF) following Fc or 







































































































Fig. 2.13 TFF2 mediated signaling cascades are only partially dependent upon LINGO3. (a) 
p-STAT3 representative  images of colon following TFF2-Fc treatment 10 days post 2.5% DSS (Magnifica-
tion 20x)  (b) Quantification of p-STAT3+ epithelial cells per highpowerfield following Fc or TFF2-Fc treat-
ment 10 days post 2.5% DSS administration (c) Representative `-catenin stain in epithelium of colons 
following TFF2-Fc treatment 10 days post 2.5% DSS (d) Percent of `-catenin stain in epithelium of colons 
following TFF2-Fc treatment 10 days post 2.5% DSS (e) Representative Ki-67+ cells in epithelium of 
colons following TFF2-Fc treatment 10 days post 2.5% DSS (f) Quantification Ki-67+ cells per highpower-
field (g) Representative cleaved caspase 3+ cells in epithelium of colons (h) Quantification of cleaved 
caspase-3+ cells per highpowerfield.  Mean ± SEM from n=4-6 cohoused mice/genotype/ 4 images per 
mouse. 2-3 independent experiments. 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Chapter 3: Lingo3 deficiency does not confer susceptibility to the enteropathogenic 
bacterium, Citrobacter rodentium 
Abstract 
 The intestinal epithelium is a complex network of cells and proteins that work in 
conjunction with one another to protect against pathogenic insult or chemical injury. 
However, during a pathogenic invasion, whether that be viral or bacterial, the intestinal 
epithelium can become injured allowing entry of pathogens into the lamina propria, leading 
to inflammatory immune responses. Citrobacter rodentium (C. rodentium) is a Gram-
negative attaching and effacing bacterium that infects rodents through attachment to 
intestinal epithelial cells. Although much is known about how C. rodentium infects host 
cells and the immune response it induces within the host, it is not well understood the 
necessary signaling pathways and proteins required to prevent infection. Herein, we have 
identified a novel receptor, LINGO3, which regulates barrier integrity and tissue repair 
during colitis. Because of LINGO3’s role in protection against colitis, we assessed if 
LINGO3 was also necessary during control of bacterial infection. We demonstrate that 
Lingo3 deficiency does not confer susceptibility to C. rodentium, albeit, Lingo3 deficiency 
does lead to enhanced Type 1 immune responses during C. rodentium infection. Combined 
we propose that LINGO3 is a novel protein that is not necessary for controlling bacterial 
burden but is necessary for controlling immune responses during C. rodentium infection. 
Introduction 
 Escherichia coli (E. coli) is a commensal bacterium that colonizes the GI tract and 
lives in symbiosis with the host. However, there of a variety of E. coli strains that can lead 
to GI diseases (Tenaillon et al., 2010). Enterohaemorrhagic E. coli (EHEC) and 
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Enteropathogenic E. coli (EPEC) are two strains that can cause fatal diarrhea (Kaper et al., 
2004). Within the United States alone, the Center for Disease and Control estimates 
265,000 E. coli cases a year occur, causing severe food poisoning 
(https://www.who.int/news-room/fact-sheets/detail/e-coli). The number of these cases 
increases in developing countries, leading to severe illness, and sometimes death 
(Agbodaze et al., 1988; Haghi et al., 2014; Okeke, 2009). Therefore, a better understanding 
of how these strains of E. coli evade the hosts immune system is crucial for development 
of vaccines and new treatments. 
 EPEC and EHEC are a part of a family of bacteria that form attachment and 
effacement (A/E) lesions on intestinal epithelial cells (Hartland and Leong, 2013; Jerse et 
al., 1990). Following attachment, these bacteria use their pathogenicity island known as 
the locus of enterocyte effacement (LEE) which encodes a Type III secretion system that 
can translocate bacterial proteins into the cytoplasm of the host cell (Deng et al., 2004; 
McDaniel et al., 1995). To better understand the pathogenicity of EPEC and EHEC and 
how these bacteria evade the host immune response, the murine pathogen Citrobacter 
rodentium (C. rodentium), has been used as a model (Schauer and Falkow, 1993a). 
 In chapter 1, the pathogenesis and immune responses induced by C. rodentium were 
discussed briefly. Important to note is upon secretion of the Type III secretion system, Tir, 
a Type III secretion system effector, is inserted into the host plasma membrane, where it 
binds to its receptor, Intimin, and triggers actin polymerization. 
Without Tir, Intimin, or the Type III secretion system C. rodentium is aviral (Deng et al., 
2003; Petty et al., 2010; Schauer and Falkow, 1993b). Interestingly, IL-22 is crucial for 
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the clearance of this bacteria (Zheng et al., 2008). Work from Tsai et al has demonstrated 
that IL-22 can upregulate the tight junction protein claudin 2, which limits tissue damage 
and promotes clearance (Tsai et al., 2017). Furthermore, leucine rich repeat proteins, such 
as toll like receptor 2 (TLR2) have been shown to be necessary for induction of 
inflammatory responses against enteric pathogens (Gibson et al., 2008b). The TLR adaptor 
protein myeloid differentiation factor (Myd) 88 can control pathogen burden through 
promotion of epithelial proliferation, induction of neutrophils, and maintenance of tight 
junction proteins (Gibson et al., 2008a; Gibson et al., 2008b; Lebeis et al., 2007), however 
whether or not other leucine rich repeat proteins play a protective role in C. rodentium 
pathogenesis is not well understood. 
 LINGO3 is a 64 kDa leucine rich repeat protein expressed in intestinal epithelial 
cells (Fig 2.1c). Upon gene deletion, mice have a barrier defect, disruption of tight junction 
proteins, enhanced Type 1 immune responses, and fail to recover from DSS- induced colitis 
(discussed in chapter 2). C. rodentium is also used as a model of colitis since infection 
induces colonic hyperplasia, and microbiota dysbiosis (Lupp et al., 2007; Mundy et al., 
2005); therefore, we evaluated the role of Lingo3 deficiency during C. rodentium infection. 
Herein we demonstrate that Lingo3 deficient mice do not confer susceptibility or resistance 
to C. rodentium infection regardless of a stronger Type 1 immune responses during C. 
rodentium infection compared to WT mice. Together, these data demonstrate that LINGO3 
is an epithelial protein that does not control bacterial burdens against a Type 1 inducing 
enteropathogenic bacterium. 
Results 
Lingo3 deficiency leads to increased TLR mRNA levels but does not confer resistance 
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to C. rodentium infection 
 WT C57Bl/6 mice clear C. rodentium infection within three weeks of infection 
(Schauer and Falkow, 1993a; Wiles et al., 2004). However, during the course of C. 
rodentium infection mice have diarrhea, can lose weight, and have colonic hyperplasia 
(Schauer and Falkow, 1993a; Wiles et al., 2004). C. rodentium infection requires a Type 1 
immune response as well as TLR signaling for clearance (Gibson et al., 2008a; Gibson et 
al., 2008b; Simmons et al., 2003; Simmons et al., 2002). In chapter 2 we have discussed 
that Lingo3 deficiency confers enhanced Type 1 immune responses at steady- state. 
Because Lingo3 KO mice have a gut permeability defect, and commensals such as 
E. coli can enter into the lamina propria, we reasoned that TLR expression may be 
increased. TLR2 is a toll like receptor that specifically recognizes acylated bacteria while 
TLR4 recognizes lipopolysaccharides, a polysaccharide commonly found in both Gram- 
positive and Gram-negative bacteria (Cario et al., 2000; Lien et al., 1999). Using RT- PCR, 
we evaluated the mRNA levels of Tlr2 and Tlr4 within IEC fraction of the colon and small 
intestine. Not surprisingly, mRNA levels for Tlr2 were increased in Lingo3 deficient IECs 
compared to WT (Fig 3.1a). We did not observe any difference in mRNA levels of Tlr4 
between genotypes (Fig 3.1b). Because TLR2 is critical for control of C. rodentium we 
reasoned that together with enhanced Type 1 immune responses as well as enhanced 
mRNA levels of TLR2, Lingo3 KO mice would be resistant to C. rodentium infection. To 
this end, we orally infected WT and Lingo3 KO mice with 10^8 colony forming units 
(colony forming units), a moderate dose, of C. rodentium. Following infection, mice were 
weighed, and bacteria burden assessed within feces every three days for twelve days of 
infection. Interestingly, following infection both WT and Lingo3 KO mice had similar fecal 
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burdens (Fig 3.2a). To confirm that C. rodentium was in fact the bacteria that was growing 
from feces on Difco MacConkey agar plates, a PCR was performed for the C. rodentium 
protein espB. All purple colonies that grew on Difco MacConkey agar plates were positive 
for espB (Fig 3.2b). Because C. rodentium infection can cause weight loss, we next 
assessed weight change over the course of infection. Neither Lingo3 KO nor WT mice lost 
weight during 12 days of C. rodentium infection (Fig 3.3). C. rodentium is shed within 
feces during infection, however, high C. rodentium fecal burden could be demonstrative of 
mice clearing C. rodentium faster. To better assess whether or not Lingo3 KO mice were 
clearing C. rodentium infection as efficiently as WT mice we next assessed dissemination 
of C. rodentium in peripheral organs. We observed no differences in C. rodentium bacterial 
burden in colon, cecum, MLN, Peyer’s patches (PP), or spleen (Fig 3.4). Together, these 
data demonstrate, despite enhanced Type 1 immune responses and mRNA levels of Tlr2 at 
steady-state, Lingo3 KO mice do not confer resistance to C. rodentium infection. 
Lingo3 deficiency does not confer resistance to high dose C. rodentium infection 
 Although Lingo3 KO mice did not confer resistance to C. rodentium infection when 
orally infected with a moderate dose of bacteria, we reasoned that it is possible Lingo3 
deficiency could confer resistance in a dose dependent manner. To assess this, we infected 
WT and Lingo3 KO mice with a high dose of C. rodentium infection (1011 CFU). 
Following infection with 1011 CFU, Lingo3 KO mice had similar fecal bacterial burdens 
as compared to WT mice (Fig 3.5a). Furthermore, neither weight loss nor organ 
dissemination was changed between genotypes (Fig 3.5b-c). Together, these data 
demonstrate regardless of C. rodentium inoculum dose, Lingo3 deficiency does not confer 
resistance to C. rodentium infection. 
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Lingo3 KO mice have enhanced Type 1 immunes responses during C. rodentium 
infection 
  Control and clearance of C. rodentium infection requires CD4+ T cells (Shiomi et 
al., 2010; Simmons et al., 2003). Since Lingo3 KO mice have enhanced Type 1 immune 
responses at steady state, we reasoned that these immune responses help to control C. 
rodentium burdens within Lingo3 KO mice. Using enzyme linked immunosorbent assay 
(ELISA), we assessed Type 1 immune responses from MLN of infected WT and Lingo3 
KO mice. Following high dose of C. rodentium infection, IL-17A, IL-22, and IFNg protein 
levels were increased in Lingo3 KO mice as compared to WT mice (Fig 3.6a-c). Together, 
these data show that despite C. rodentium burdens being similar between WT and Lingo3 
KO mice, Lingo3 deficiency leads to enhanced Type 1 immune responses during C. 
rodentium infection. 
Discussion 
 Citrobacter rodentium is a Gram-negative bacterium that is used as a model system 
to study E. coli infections as well as colitis. Although C. rodentium causes colonic 
hyperplasia, colonic shortening, and a Type 1 immune response, similar to DSS-induced 
colitis, it does not cause intestinal epithelial damage that is commonly found in DSS- 
induced colitis as well as IBD patients (Chassaing et al., 2014; Fakhoury et al., 2014; 
Luperchio and Schauer, 2001). Therefore, the use of C. rodentium along with DSS can 
begin to distinguish roles of proteins and signaling pathways within inflammation induced 
during colitis as well as repair mechanisms necessary to prevent colitis, respectively. 
 The work shown in this study demonstrate that despite enhanced Type 1 immune 
responses at steady -state, Lingo3 KO mice are not resistant to C. rodentium infection 
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regardless of inoculum dose. Interestingly, despite not having lower C. rodentium burdens 
compared to WT mice, Lingo3 KO mice maintain a statistically significant increase in Type 
1 immune responses compared to WT mice during C. rodentium infection. These findings 
suggest that although Lingo3 KO mice have similar levels of fecal bacterial burden and 
dissemination as compared to WT, the enhanced Type 1 immune response could in part be 
responsible for maintaining control of C. rodentium. 
 In chapter 2 we have demonstrated that Lingo3 KO mice have a gut permeability 
defect associated with dysregulated adherens junction formation. Additionally, C. 
rodentium infection can disrupt tight junction complexes such that deficiency in these 
protein complexes allows for increased bacterial burdens (Guttman et al., 2006; Tsai et al., 
2017). Given these data, one alternative hypothesis for the findings in this chapter could 
be that Lingo3 KO mice would be more susceptible to C. rodentium, since a permeability 
defect can allow C. rodentium infection to enter into the lamina propria more efficiently. 
However, since Lingo3 KO mice have enhanced mRNA levels of Tlr2 along with enhanced 
Type 1 immune responses, it is possible that these signaling pathways are in part 
responsible for controlling C. rodentium burdens to similar levels as WT mice. 
Interestingly, enhanced mRNA expression of TLR2 at steady-state suggest that there is, to 
some extent, microbial dysbiosis within the Lingo3 KO mice. 
 TLRs are leucine rich repeat proteins and members of the pattern recognition 
receptor family (Hug et al., 2018). These receptors sense pathogenic insults and induce an 
immune response to pathogens (Hug et al., 2018). Additionally, during bacterial infection 
TLRs, specifically TLR2 and TLR4 become upregulated (Davey et al., 2008; Dessein et 
al., 2009; Rosenstiel et al., 2007). The enhanced mRNA expression of Tlr2 but not Tlr4 in 
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IECs isolated from Lingo3 KO mice is surprising because during inflammatory conditions 
within the GI tract, typically Tlr2 and Tlr4 expression is increased (Cario and Podolsky, 
2000; Hausmann et al., 2002). We have demonstrated that Tlr2 mRNA levels are increased 
within IECs isolated from Lingo3 KO mice further support inflammatory conditions within 
these mice at steady-state despite comparable histology within the GI tract (Fig 2.2b, Fig 
2.5b-c). Because the enhanced Tlr2 mRNA expression levels could be a secondary effect 
to the gut permeability defect observed within these Lingo3 KO mice, it will be important 
in future studies to understand if Lingo3 KO mice become more susceptible to C. rodentium 
following antibiotic treatment. Prophylaxis treatment with antibiotics is well known to 
eradicate commensal bacterium within the GI tract (Brandl et al., 2008; Buffie et al., 2012; 
Lewis et al., 2015). Furthermore, eradication of commensal bacteria can lead to 
susceptibility of bacterial infections such as Clostridium difficile (Buffie et al., 2012). 
Therefore, it is possible Lingo3 KO mice have enhanced Type 1 immune responses at 
steady-state due to the permeability defect discussed in Chapter 2, therefore treatment of 
Lingo3 KO mice with antibiotics prior to C. rodentium infection would decrease enhanced 
Type 1 immune responses and render Lingo3 KO mice susceptible to C. rodentium 
infection. 
  Importantly, the work shown here does not demonstrate that Lingo3 KO mice clear 
infection. It is well known that WT C57Bl/6 mice with normal immune systems (functional 
CD4+ T cell and B cells) can clear C. rodentium infection within three weeks (Maaser et 
al., 2004; Shiomi et al., 2010; Simmons et al., 2003; Simmons et al., 2002). Previous 
reports have demonstrated that during early C. rodentium infection (day 0- day 6) the innate 
immune response, specifically, IL-22 secretion from ILC3 and LTis are critical for early 
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control (Sonnenberg et al., 2011; Zheng et al., 2008). Additionally, during late control of 
C. rodentium infection (post day 6-8), that adaptive immune response including IFNg is 
critical for control of C. rodentium burden (Shiomi et al., 2010; Simmons et al., 2002). To 
date, C. rodentium burden has only been evaluated within Lingo3 KO mice through day 12 
post infection and whether or not Lingo3 KO mice can clear C. rodentium infection faster 
than WT mice has not been evaluated. It is possible that Lingo3 KO mice can clear C. 
rodentium infection faster than WT mice, however, prophylactic administration of 
antibiotics prior to C. rodentium may ablate this effect. Therefore, future work will evaluate 
the implications of LINGO3 during clearance of C. rodentium infection. 
 Colonic hyperplasia is described as the thickening and increased rate of epithelial 
proliferation within the colon (Barthold and Jonas, 1977). Colonic hyperplasia is a 
hallmark histological pathology associated with C. rodentium infection (Mundy et al., 
2005). Along with colonic hyperplasia, C. rodentium infection is associated with a decrease 
in goblet cell numbers (Bergstrom et al., 2008). Bergstrom et al demonstrated that C. 
rodentium directly interacts with goblet cells and during the peak of C. rodentium infection 
there is a decrease in goblet cells and expression levels of goblet cell-derived MUC2 and 
TFF3 (Bergstrom et al., 2008). Follow up studies, demonstrated that reconstitution of Rag1 
KO mice with CD4+ T cells led to the depletion of goblet cells and worsened pathology 
during C. rodentium infection (Chan et al., 2013). Additionally, Rag1 KO mice had similar 
C. rodentium burdens as compared to Rag1 KO mice reconstituted with either CD4+ or 
CD8+ T cells, despite being more susceptible to mortality (Bergstrom et al., 2008; Chan et 
al., 2013). These data suggest that the presence of T cells reduces mortality, however, 
increases pathology during C. rodentium infection (Chan et al., 2013). We have 
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demonstrated that Lingo3 KO and WT mice have comparable fecal and peripheral organ 
C. rodentium bacteria burdens; however, we do not know whether or not pathology is 
different between the two genotypes. Given the enhanced Type 1 immune responses within 
Lingo3 KO mice at steady-state (Chapter 2) and during C. rodentium infection it is possible 
that Lingo3 KO mice have worsened pathology. To further investigate this hypothesis, 
evaluating colonic hyperplasia, goblet cell numbers via PAS-stained tissues, as well as 
colon length during 21 days of C. rodentium infection will provide insight into the role of 
LINGO3 during inflammation- induced pathology. 
 Together the work shown here, demonstrate the Lingo3 deficiency does not affect 
bacterial burdens or dissemination of C. rodentium during 12 days of moderate and high 
dose infection. Similar to the steady-state findings, Lingo3 KO mice maintain a statistically 
significant increased Type 1 immune response during C. rodentium infection as compared 
to WT mice. Importantly, these data do not evaluate the role of LINGO3 on worsened 
pathology during C. rodentium infection, a phenotype associated with persistent Type 1 
immune responses. Although these findings suggest that LINGO3 does not have a 
functional role in controlling bacteria burden, these studies cannot yet rule out whether 
LINGO3 is important for clearance of C. rodentium. Future studies will be undergone to 
better understand if LINGO3 controls inflammation-induced pathology and the effects of 
Lingo3 deficiency on goblet cell depletion. 
Methods 
 Mice. All animal procedures were approved by the Institutional Animal Care and 
Use Committee at University of California, San Francisco. WT C57BL6 mice were bred 
in house. Super-ovulated female C57BL/6 mice (4 weeks old) were mated to C57BL/6 stud 
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males. Fertilized zygotes were collected from oviducts and injected with Cas9 protein (30 
ng/µl), sgRNA (15 ng/µl) into pronucleus of fertilized zygotes. Injected zygotes were 
implanted into oviducts of pseudo pregnant CD1 female mice. Animals were housed under 
specific-pathogen free barriers in vivarium at San Francisco General Hospital or University 
of Pennsylvania. All procedures were reviewed and approved by IACUC at University of 
California at San Francisco (protocol #AN109782-01) and University of Pennsylvania 
(protocol #805911). 
 Quantitative RT-PCR. For intestinal epithelial cell isolation, small intestines were 
dissected from WT and Lingo3 KO mice and cut open longitudinally. Intestines were 
washed 3X in Hank’s Buffered Saline Solution (HBSS) containing 5mM EDTA+ 2.5mM 
DTT for 10 mins shaking at 37ºC. Following 10min incubation intestines were vigorously 
shaken by hand using forceps, epithelial cell fraction was collected. Following 3X washes 
epithelial fractions were spun down at 1500 RPM for 5 min, and supernatants were 
aspirated. Cell pellets were then resuspended in 10 mL HBSS and filtered through a 70 
micron strainer and centrifuged for 5 minutes at 1500 RPM. Cells pellets were resuspended 
in 1 mL HBSS and filtered through a 40 micron strainer centrifuged at 1500 RPM for 10 
mins. Following centrifugation RNA was purified from cell subsets using nucleospin RNA 
plus kit (clontech # 740984.25). cDNA was prepared using 1µL of 100 ng Random primers 
(Invitrogen), 1 µg of RNA, 10 mM dNTP (Invitrogen), and 1 µL of Maxima H Reverse 
Transcriptase (ThermoFisher #EP0752). PCRs were set up in a final volume of 20 µL using 
2uL DNA, 1 µL 20 µM Forward and reverse primer, and 2X Sybr Green I Master Mix 
(Bio-Rad #172-5274). Gene expression was measured using BIO- RAD CFX machine and 
data normalized to GAPDH and presented as MEAN ± SEM from the replicates. The 
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primer sequences are as follows: espB Forward primer (5’ 
ATGCCGCAGATGAGACAGTTG3’),  
espB Reverse primer (5’CGTCAGCAGCCTTTTCAGCTA 3’),  
TLR2 Forward primer (5’CACTTTATTCAGAGCCGTTGG 3’),  
TLR2 Reverse primer (5’ TCTCCAGAAGATGTGCCTCC 3’),  
TLR4 Forward primer (5’ CACTTTATTCAGAGCCGTTGG 3’),  
TLR4 Reverse primer (5’ TCTCCAGAAGATGTGCCTCC 3’). All real-time PCR 
reactions were carried out on Bio-Rad CFX96 system and data were analyzed using the CT 
method as recommended in the manual. 
 C. rodentium infection. WT and Lingo3 KO male mice (2-3 months old) were 
cohoused for 4 weeks prior to infection. Mice were fasted for 16-18 hours prior to infection. 
Mice were weighed and fecals collected every 3 days throughout the course of infection. 
C. rodentium strain DBS100 was provided by the Wu lab (University of Pennsylvania). 
Prior to infections, a C. rodentium colony was grown overnight for 16 hours. The following 
morning a 1:10 dilution of overnight C. rodentium was performed in LB broth Miller 
(Fisher Scientific #244620). Using a spectrometer, an OD600 reading was performed on 
the diluted C. rodentium to get an OD600 of 1 mL of overnight culture. This value was 
then used as a conversion factor for subsequent experiments. For infections: two days prior 
to infection, a glycerol stock of C. rodentium was thawed and streaked on a Difco 
MacConkey agar plate (Fischer Scientific #DF0075-17-1) and incubated overnight at 37C. 
one day prior to infection 1 C. rodentium colony was picked and inoculated into 3 mLs of 
LB Broth miller overnight at 37C in a shaking incubator. 16 hours post shaking at 37C, a 
1:10 dilution of 16hr grown C. rodentium was measured using a Spectrometer. Mice were 
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orally infected 200 µL of either 108 or 1011 C. rodentium. To calculate the volume of C. 
rodentium needed for each infection the total CFU (desired CFU X number of mice) was 
divided by the CFU of 16 hr culture. The volume of C. rodentium required for infection 
was centrifuged at 10,000 RPM for 10 minutes and resuspended in appropriate volume of 
1X Sterile PBS. Following oral infection, excess of 16hr C. rodentium was serially diluted 
and plated on Difco MacConkey agar filled Bi-plates (Fisher Scientific #FB08757150). 50 
µL of serially diluted C. rodentium was plated on each side of bi-plate petri dish and spread 
using a bacterial spreader. Plates were then incubated upside down at 37C for 24 hours. 
Purple colonies were counted the following days and multiplied by serial dilution X 2 (to 
account for the 1:10 dilution) which gave the amount of CFU. For fecal burdens, 2-3 fecal 
pellets were collected every three days and weighed. 1 mL of sterile 1x PBS was added to 
each fecal tube and made into a fecal slurry. For organ bacterial burden, spleen, colon, 
cecum, liver, kidney, MLN, Peyer’s patch was weighed and homogenized by hand using a 
plastic sterilized mortal. Serial dilutions of fecals as well as organs were performed in LB 
broth Miller. Following serial dilutions, each dilution was plated as discussed above. 24hrs 
post plating colonies were counted, multiplied by the serial dilution X 2 and divided by 
weight of either fecal or organ to calculate the CFU/g. 
 ELISA. Following 12 days of C. rodentium infection, mice were euthanized, and 
MLNs were isolated and homogenized. 0.25X 106 cells/mL were plated on a CD3:CD28 
coated 96 well plate or a non-aCD3:CD28 coated 96 well plate. Plates were incubated for 
72hrs at 37C. Following incubation, plate was centrifuged at 1500 RPM for 3 minutes and 
supernatants were collected. All ELISAs were performed according to manufacturer’s 
instructions. IFNg ELISA kit (ebioscience #88-7314-88), IL-22 ELISA kit (#88-7422-88), 
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and IL-17A ELISA kit (ThermoFisher #88-7371-77). 
Statistics. Statistical analyses were performed using GraphPad Prism version 7.0 










Fig 3.1 Lingo3 KO intestinal epithelial cells have increased Tlr2 mRNA levels. 
Intestinal epithelial cells were isolated from small intestine (a) Tlr2 mRNA expression
 (b) Tlr4 mRNA expression. Representative of oneindependent experiment. 

















































Fig 3.2 WT and Lingo3 KO mice have equivalent C. rodentium burdens. 
WT and Lingo3 KO mice were orally infected with 108 colony forming units (CFU)
 of C. rodentium. (a) CFU/g of feces in WT and Lingo3 KO 12 days post 
C. rodentium infection (b) PCR for espB expression within purple colony from 
overnight fecal Difco MacConkey agar plate. Lane 1 is non template control 
(NTC), Lane 2 is expected C. rodentium (CR) colony from fecal plate, 
Lane 3 is E. coli, a negative control. Data represented is pooled from two

























Fig 3.3 WT and Lingo3 KO mice have no weight loss following infection
with  108 CFU of C. rodentium. (a) Body weight percentage (%) during 
C. rodentium infection.Data represented is pooled from two experiments. 






















Fig 3.4 WT and Lingo3 KO mice have similar C. rodentium burden in
 peripheral organs following oral infection with 108 CFU. 
(a) Bacterial burden (CFU/g) in colon, cecum, mesenteric lymph node (MLN), 
peyer’s patch (PP), Spleen during C. rodentium infection.Data represented is 






























































Fig 3.5 WT and Lingo3 KO mice have equivalent C. rodentium burdens 
following high dose infection. WT and Lingo3 KO mice were orally infected with 
1011 CFU of C. rodentium. (a) C. rodentium fecal burden over 12 days of infection
(b) Body weight percentage (Body weight (%)) over 12 days of infection
(c) Dissemination of C. rodentium in Liver, Spleen, and Cecum day 12










































Fig 3.6 Lingo3 KO mice have enhanced Type 1 immune responses
following C. rodentium infection. Whole MLN  lysates were stimulated 
with aCD3:CD28 for 72hrs following 12 days of C. rodentium infection 
(a) IL17A protein concentration (pg/mL) in supernatants (b) IL22 protein 
concentration in supernatants (c) IFNa protein concentration in supernatants. 
Mean±SEM, n=5-7 cohoused mice/ genotype. 




Chapter 4 Discussion  
Overview 
 This dissertation focused on gaining a better understanding of the cellular and 
molecular pathways underlying mucosal tissue repair. Specifically, it was designed to 
identify and characterize novel proteins that interacted with Trefoil factor proteins (TFFs), 
particularly TFF2. TFFs were first identified in the 1990s as small glycoproteins expressed 
at mucosal sites that serve functionally important roles in tissue repair (Buda et al., 2012; 
Podolsky et al., 1993; Suemori et al., 1991; Thim, 1989). Interestingly, although these 
proteins have been studied for over 20 years, exactly how these proteins promote tissue 
repair is not well understood. This lack of knowledge was due to largely the lack of 
understanding of how TFFs signal and the identity of transmembrane TFF-binding proteins 
that could confer the tissue reparative functions of these secreted factors. Recent work from 
my dissertation laboratory has begun to elucidate novel TFF binding partners through the 
use of TRICEPS, which is a chemoproteomics-based screen that is designed to identify 
low-affinity interactions reliant upon glycoproteins (Frei et al., 2012; Frei et al., 2013). 
LINGO family of proteins were identified through this screen. Recently published work 
from Belle et al. has demonstrated that LINGO2 interacts with TFF3 and EGFR to protect 
against colitis (Belle et al., 2019). However, the understanding of whether any of the other 
remaining LINGO family members serve roles in TFF signaling and mucosal tissue repair 
was unknown prior to my thesis work. 
 The work presented herein has identified that LINGO3 is expressed within the GI 
tract as well as the lung which are two locations in which TFF2 is also expressed. 
Furthermore, we have found that LINGO3 is expressed on intestinal epithelial cells and 
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not on any of the immune cell subsets isolated and evaluated from the MLN or spleen of 
mice. Interestingly, within human rectosigmoid tissue, LINGO3 is expressed within two 
distinct locations; apically where enterocytes are found and also at the base of the colonic 
crypts where intestinal stem cells (ISCs) are found. 
 In mice lacking Lingo3, we found a basal defect in gut permeability and 
dysregulated adherens junction architecture, which is a phenotype that resembles Tff2 
deficient mice. It is well established that deficiency in the AJC within the GI tract can lead 
to entry of commensals and/or pathogenic bacteria into the lamina propria that 
subsequently drives an inflammatory immune response (Chan et al., 2013). Given the 
steady-state increase in gut permeability observed in Lingo3 deficient mice, we next 
evaluated the nature of the ongoing inflammatory response leading to find that Lingo3 
deficient mice have an increase in the overall number of intestinal DCs as well as an 
accumulation of TH1 immune cells within the lamina propria and MLN all at steady-state 
naïve specific pathogen free (SPF) conditions. 
 Defects in AJC function and resultant enhanced Type 1 inflammation are conserved 
features of IBD, which are a spectrum of diseases in which defects in TFF biology have 
been implicated (Fakhoury et al., 2014). Tff2 deficient mice are more susceptible to acute 
and chronic forms of DSS-induced colitis (Judd et al., 2015). We demonstrate that similar 
to mice with Tff2 deficiency, Lingo3 deficient mice have increased susceptibility to DSS-
induced tissue damage and immunopathology as measured by increased DAI scores, 
decreased body weight, and decreased colon lengths compared to cohoused WT mice. 
Interestingly, Lingo3 KO mice are particularly more susceptible to DSS during the tissue 
recovery phase, which is also when TFF responsiveness is most important to promote 
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healing. Additionally, work in this thesis demonstrates that LINGO3 is required for TFF2 
treatment to promote a faster recovery during DSS-induced colitis than mock-treated 
animals. We found that TFF2 requires LINGO3 to promote MAPK activation , but that 
conversely STAT3 signaling is driven through a TFF2 independent pathway that is 
dysregulated within Lingo3 KO mice during DSS-induced colitis. Although Lingo3 
deficiency leads to susceptibility during DSS- induced colitis it does not alter the outcome 
of susceptibility or resistance to the rodent enteropathogenic bacterium C. rodentium, 
which is used to model human infection with attaching effacing strains of E. coli. 
 Collectively, the body of work completed for this thesis supports a hypothesis that 
LINGO3 is a novel Type 1 transmembrane protein that is a critical for basal maintenance 
of the AJC structure, promotes tissue repair during DSS-induced colitis and partially 
confers TFF2 signaling. Future studies should be targeted to further define LINGO3 
expression patterns in the mucosa of humans and mice, define the mechanisms responsible 
for how LINGO3 regulates distinct proteins of the AJC, and whether augmenting LINGO3 
activity can directly repress Type 1 inflammation. Further investigation of these 
outstanding questions may shed light on whether LINGO3 activity can be a therapeutic 
target of IBD therapy as well as other injury models within mucosal sites that LINGO3 is 
expressed. In this chapter, the functional role for LINGO3 within the ISC niche, the 
potential implication for LINGO3 as a putative treatment for IBD, as well as broader 
implications of LINGO3 in other immune related diseases such as asthma will be 
discussed. 
4.1 The role of Lingo3 in the intestinal stem cell niche 
 As discussed in chapter 1, the ISC niche is comprised of a variety of epithelial 
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subtypes that each have a specific role in the maintenance of homeostasis and tissue repair. 
The Lgr5+ cell is a bona-fide stem cell found at the bottom of the intestinal crypt within the 
small and large intestine (Barker et al., 2007; Koo and Clevers, 2014). Work from the 
Clever’s laboratory first identified these cells from working on a hypothesis that because 
WNT signaling is the essential for crypt development that Wnt target genes would be 
specifically expressed within distinct cells of the stem cell niche (Barker et al., 2007; Sato 
et al., 2009). Since the establishment of this idea in 2007, much work has been done to 
better understand the key signaling pathways necessary for maintenance and regulation of 
the Lgr5+ cells. Demonstration that WNT3a, EGF, NOGGIN, and R- SPONDIN1 are key 
proteins required for growing intestinal organoids has greatly advanced the overall 
understanding of Lgr5+ cells (de Lau et al., 2011; Nozaki et al., 2016; Wang et al., 2017). 
In vitro organoid culture is a method that not only allows the ability to study the number 
of stem cells within a crypt, but also how the crypt can be manipulated in real time, and the 
effects that these manipulations have on the regenerative properties of the ISC niche (de 
Lau et al., 2011; Nozaki et al., 2016; Wang et al., 2017). 
 Although the Lgr5 gene has been well studied, its homologues such as Lgr4 have 
received as much attention. LGR4 is also necessary for WNT signaling within intestinal 
crypts (Kinzel et al., 2014; Xu et al., 2013). When Lgr5 and Lgr4 are simultaneously 
deleted in vivo, intestinal crypt structure is lost, and epithelial cell proliferation is decreased 
(de Lau et al., 2011). Additionally, each of the four R-SPONDIN proteins, 
which are known agonists for WNT signaling, can bind to LGR4, LGR5, and LGR6, 
suggesting that in addition to LGR5, both LGR4 and LGR6 also have functional roles 
within the ISC niche (de Lau et al., 2011). The ability of LGR4-6 to bind to R- SPONDINs, 
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is accompanied by high sequence conservation, high sequence homology and similar 
structure amongst the LGR family members (Barker and Clevers, 2010; Hauser et al., 1997; 
Herpin et al., 2004; Kudo et al., 2000; Nishi et al., 2000; Nothacker and Grimmelikhuijzen, 
1993; Tensen et al., 1994). Because of the high sequence homology and conservation of 
the LGR proteins, one can hypothesize that the LGR family of proteins have compensatory 
roles in maintenance of the ISC niche. To this end, work from Liu et al demonstrates that 
Lgr4 deficient mice have reduced Paneth and Lgr5+ cells. Furthermore, Lgr4 deficient mice 
have worsened DSS-induced colitis and a defect in cellular proliferation (Liu et al., 2013). 
Curiously, the phenotype of Lgr4 deficient mice is quite similar to the phenotype of Lingo3 
KO mice during DSS-induced colitis. It is therefore possible that there is some degree of 
overlap in the function of LGR4 and LINGO3. Interestingly, LINGO1 bears some degree 
of structural similarity to LGR4 (Xu et al., 2013). This finding is extremely noteworthy 
because the LINGO family members, like LGR family members, share sequence homology 
amongst one another (Mi et al., 2004). More importantly, because LINGO1 is known to 
form a receptor signaling complex with two other proteins, Nogo-66 receptor and p-75 
signaling complex, it is plausible that other LINGO family members similarly form 
receptor complexes, perhaps even with receptors in the LGR family of proteins (Inoue et 
al., 2007; Mi et al., 2004; Pepinsky et al., 2014). 
 In chapter 2, I discuss the expression pattern of LINGO3 in human rectosigmoid 
tissue samples. We find expression of this protein in two anatomically distinct locations, 
apically where enterocytes are found, and at the base of the crypt where Lgr5+ stem cells 
are found. Additionally, we observe that both small and large intestinal organoids grown 
from Lingo3 KO and Tff2 KO mice have marked developmental abnormalities. Small 
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intestinal organoids from Lingo3 KO and Tff2 KO mice do not develop buds as efficiently 
as WT organoids over the days of growth evaluated. Colonic organoids from Lingo3 KO 
and Tff2 KO mice do not have obvious defects in budding but do display defects in 
maintaining their 3D architecture. These differences in budding, growth and architecture 
within Lingo3 KO small intestinal and colonic organoids could be in part because colonic 
organoids require more WNT signaling as compared to small intestinal organoids (Mahe 
et al., 2013). Since Tff2 KO organoids have a similar defective phenotype as compared to 
Lingo3 KO organoids further supports a hypothesis that LINGO3 and TFF2 have important 
functions in the maintenance of the ISC niche. 
 To date, there have been no publications implicating TFFs in the maintenance or 
development of the ISC niche. Interestingly, the Tumor necrosis factor receptor 
superfamily member 19 (TROY), a p75-neurotropin receptor family member that is a part 
of the LINGO1 complex, can interact with LGR5 to inhibit WNT signaling (Fafilek et al., 
2013; Mi et al., 2004; Satoh et al., 2007). Fafilek et al demonstrated that Troy deficient 
organoids maintained cellular proliferation in the absence of R-SPONDIN 1, while WT 
organoids did not (Fafilek et al., 2013). Moreover, if Troy deficient organoids are 
supplemented with 15 ng/mL of R-SPONDIN 1, which is a concentration that is sixty-six 
times lower than the normal concentration of R-SPONDIN1 used in organoid cultures, 
these organoids could then proliferate for weeks, while WT organoids arrested (Fafilek et 
al., 2013). These data suggest that TROY is a negative regulator of WNT signaling. 
 Although the crystal structure of LINGO3 is currently not known, given the 
conservation among the LINGO proteins, combined with the known interaction between 
LINGO1 and TROY, it is possible that the LINGO proteins can interact with LGR4, LGR5 
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and/or LGR6 and modulate WNT signaling and maintenance of the ISC niche (Fig. 4.1). 
In support of this model,  preliminary bulk RNA sequencing data demonstrate that IECs 
isolated from Lingo3 KO mice have dysregulated Wnt target genes (data not shown). 
Understanding the role of these Wnt target genes within the ISC niche may help to better 
understand whether or not LINGO3 regulates WNT signaling similar to TROY. The ability 
to control the on/off switch of Wnt signaling transcriptionally and translationally is 
necessary for maintenance of the ISC niche. Given these preliminary results, future work 
should focus on biochemical assays that assess whether LINGO3 can form a protein 
complex with any of the LGRs. Because both Tff2 KO and Lingo3 KO organoids have 
similar defects, it is possible that a LINGO3-TFF2 signaling pathway is required for normal 
WNT signaling. Future experiments should test if the addition of recombinant TFF2 can 
promote normal organoid architecture and growth within Lingo3 KO and/or Tff2 KO small 
or large intestinal organoids. Finally, based on the data within this dissertation, we have 
hypothesized that WNT signaling is dysregulated, but we do not know whether or not WNT 
signaling is upregulated or downregulated; therefore, assessing protein concentrations of 
different WNT ligands within organoid cultures and changing the concentration of WNT3a 
added to organoid cultures should further our understanding of how LINGO3 and TFF2 
regulate WNT signaling. Given the dysregulation within Lingo3 deficient organoids  one 
model prediction is that LINGO3 expression can potentially regulate the secretion of WNT 
ligands, leading to dysregulation of WNT when Lingo3 is genetically deleted (Fig 4.1).  
 Beyond ISCs themselves, work from the Regev lab has demonstrated that Lingo3 
is expressed on transit amplifying (TA) cells (Lauber et al., 1989). These are cells that are 
found within the ISC niche but instead of sitting at the base of the crypt they are typically 
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found at the start of the villus, closer to +4 quiescent cells (Lauber et al., 1989). Recent 
work has demonstrated that these cells promote proliferation of previously primed stem 
cells as well as quiescent stem cells and require the Sonic Hedgehog signaling pathway 
(Hsu et al., 2014). To date, there have not been studies of TA cells functional role in tissue 
regeneration or repair during IBD. There is one study that demonstrates the IL22 receptor 
A1 is expressed on TA cells (Zwarycz et al., 2019). This study demonstrates that increased 
levels of IL22 in vivo can increase proliferation of TA cells but has no proliferative effects 
on the Lgr5+ population (Zwarycz et al., 2019). Work shown in chapter 3 demonstrates that 
Lingo3 KO mice have enhanced IL22 cytokine secretion following 72 hours of stimulation 
with aCD3:CD28 post C. rodentium infection. Given the data known about TA cells and 
the increase in IL-22 secretion within Lingo3 KO mice, it is possible that there is a 
dysregulation in the TA cell compartment within Lingo3 deficient mice. Paneth cells have 
been implicated in providing compensatory role to Lgr5+ cells during the recovery phase 
of DSS-induced injury (Schmitt et al., 2018). Therefore, it is possible that TA cells act in 
a similar fashion. One hypothesis is that if LINGO3 is expressed within the TA cell subset 
and functions in a similar manner to TROY that inhibits WNT signaling, then it is possible 
that Lingo3 deficient mice also have a dysregulated TA cell compartment as well as 
dysregulation of WNT signaling (Fig 4.1).  
 The impact of Lingo3 deficiency on the ISC niche within the small and large 
intestine remains to be fully characterized. Future experiments should assess whether there 
are differences within epithelial cell subtypes present in this location such as Paneth cells, 
Lgr5+ cells, and TA cells. Based on the work completed for this thesis, it is likely one or 
more of these epithelial cell progenitor populations are dysregulated within the Lingo3 KO 
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mice compared to WT mice. Both Paneth cells and Lgr5+ cells have been shown to be 
necessary during the tissue regenerative stage of DSS-induced colitis, therefore, a defect 
in one or both of these populations could explain at least in part, the abnormal phenotypes 
observed within the Lingo3 KO mice (Davidson et al., 2012; Schmitt et al., 2018). It is 
unlikely that there is a severe defect in ISC biology such as the complete loss of one or 
more of these populations, because the loss of Lgr5 expression is incompatible with life. A 
more likely scenario is that there is  an alteration in some aspect of the biology of the cells, 
perhaps a moderate reduction in overall number or position of cells within the ISC niche 
of Lingo3 KO mice (Fig 4.1) (Kinzel et al., 2014). 
4.2 The functional role of Lingo3 in AJC and cellular motility 
 In chapter 2, we demonstrate that colonic organoids from Lingo3 KO and Tff2 KO 
mice have a defect in 3-dimensional (3D) architecture which manifests as a conversion to 
a flattened 2-dimensional (2D) appearance. This defect in architecture could be caused by 
the identified AJC defects leading to the overall increase in gut permeability that occurs in 
both Lingo3 KO and Tff2 KO mice. Additional research needs to be performed to 
understand which proteins of the AJC are dysregulated within the Tff2 KO mice; however; 
we show using electron microscopy that within the jejunum and colon of Lingo3 KO mice 
this region of the apical junction is dysregulated. This data is further supported by the 
decrease in E-cadherin both at the mRNA and protein level. It has previously been 
established that polymorphisms within E-cadherin can lead to IBD (Bates and Mercurio, 
2003; Grill et al., 2015; Hahn et al., 2017; Muise et al., 2009; Wendt et al., 2011). 
Additionally, defects in the epithelial-mesenchymal transition promote a 2D architecture 
within organoids (Bates and Mercurio, 2003; Grill et al., 2015; Hahn et al., 2017; Muise et 
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al., 2009; Wendt et al., 2011). Our RNA sequencing data comparing WT and Lingo3 KO 
mice under steady-state conditions demonstrates that IECs isolated from the GI tract of 
Lingo3 KO mice have a decrease in expression of genes associated with the epithelial-
mesenchymal transition (data not shown). Given these data, it is possible that the defect in 
colonic organoids is in part due to dysregulated function (s) of the adherens junction. 
Therefore, it is possible that LINGO3 can indirectly or directly regulate the formation of 
the apical junction complex (Fig 4.2). 
 E-cadherin can form a complex with CD103 and b-catenin to form the adherens 
junction (Coopman and Djiane, 2016; Van den Bossche et al., 2012). In Chapter 1, the role 
of b-catenin within WNT signaling was discussed. In short, the binding of WNT to its 
receptors, Frizzled and LRP5/6 turns off the b -catenin degradation complex which allows 
for b -catenin to accumulate within the nucleus and associate with LEF/TCF complex 
inducing the transcription of Wnt responsive genes (Behrens et al., 1996; Molenaar et al., 
1996; Moparthi and Koch, 2019). In addition to b -catenin’s role in WNT signaling, 
following complex formation with E-cadherin and integrins, b -catenin binds to a-catenin 
which can bind actin (Adhikari et al., 2018; Campbell et al., 2017). Therefore, our model 
predicts that any dysregulation in one of these signaling complexes/mechanisms could lead 
to disrupted adherens junction, intestinal permeability, and defects in organoid 
architecture/growth (Fig 4.2).  
 In chapter  2 , we demonstrate that Lingo3 deficiency dysregulates adherens 
junction architecture via electron microscopy (EM) (Fig 2.7). Interestingly, within both 
Lingo3 KO colon and jejunum EM images, a looped-like structure could be observed in 
place of a more linear adherens junction configuration seen within EM images of WT mice. 
105  
One potential hypothesis for the formation of looped-like adherens junction could be 
dysregulation of actin filaments and actin cytoskeleton. The AJC has been well known to 
form and bind to actin through a -catenin (Campbell et al., 2017). Mutations within either 
b-catenin or a- catenin can disrupt cell adhesion as well as polarization of the actin 
cytoskeleton (Orsulic and Peifer, 1996). Consequently, a potential dysregulation of the 
Wnt- b-catenin signaling pathway could also have a role in dysregulation of actin 
polarization in addition to adherens junctions. 
 Polymerization of actin requires actin-related proteins 2 and 3 (ARP2/3) complex 
and nucleation-promoting factors, namely Wiskott-Aldrich syndrome protein (WASP), 
which can bind actin monomers and the ARP 2/3 complex (Marchand et al., 2001; 
Rodnick-Smith et al., 2016). Upon binding, the Arp 2/3 complex becomes activated and 
can form new actin filaments leading to branched actin networks (Marchand et al., 2001; 
Rodnick-Smith et al., 2016). Interestingly a-catenin can regulate actin polymerization by 
suppression of the ARP 2/3 complex (Drees et al., 2005). Therefore, a normal adherens 
junction formation is necessary for regulated actin polymerization. One hypothesis is that 
dysregulation in either the Wnt- b-catenin signaling, or the E-cadherin- b-catenin complex 
can lead to aberrant formation of actin polymerization (Fig 4.2). Moreover, actin 
polymerization is necessary for cell motility (Carlier and Pantaloni, 1997; Carlier et al., 
1999). 
 During tissue injury, the process of cellular restitution is critical for successful 
tissue repair. Restitution is defined as the movement of cells over areas of denuded 
basement membrane at the site of injury (Aihara et al., 2018). This cellular restitution is 
initiated by actin polymerization (Aihara et al., 2018). To date TFFs have not been shown 
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to regulate actin polymerization, but instead have been shown to promote cellular 
restitution during injury (Xue et al., 2010). Taken together, one potential explanation for 
the loop-like structures within adherens junction of Lingo3 KO colon and jejunum could 
be dysregulated Wnt- b-catenin signaling, leading to the disruption of the E-cadherin- b 
catenin complex and subsequent binding of a-catenin to actin filaments. Alternatively, 
LINGO3 signaling could indirectly promote formation of the E-cadherin- b-catenin 
complex, therefore Lingo3 deficiency results in a defective complex. Although we have no 
evidence that LINGO3 can directly bind to b-catenin or E-cadherin, published data within 
the Herbert laboratory demonstrates that Lingo2 deficient mice also have a gut permeability 
defect implying a similar phenotypic alteration as observed with Lingo3 deficiency (Belle 
et al., 2019). Because either Lingo2 or Lingo3 deficiency leads to increased gut 
permeability, it is possible that the LINGO family of proteins can bind to and regulate the 
AJC proteins necessary for maintenance of this complex. A defect within b-catenin could 
lead to dysregulation of actin polymerization and in part lead to a defect in cellular 
restitution during tissue injury as observed during DSS-induced colitis. In chapter 2 we 
demonstrate that TFF2 requires LINGO3 for MAPK activation during DSS- induced 
injury. It is possible that TFF2 also requires LINGO3 for cellular restitution, and that a 
defect in either Lingo3 or Tff2 can cause dysregulated E-cadherin- b-catenin complex.  
 Previous reports have demonstrated that administration of TFF3 can promote 
expression of tight junction proteins such as claudins while reducing protein levels of 
cadherin, a-and b-catenin, as well as a decrease in actin ring formation (as measured by 
phalloidin staining) (Buda et al., 2012; Meyer zum Buschenfelde et al., 2004). There are 
no reports implicating TFF2 signaling on the formation of the AJC or actin polymerization. 
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A potential scenario that could be possible is that TFF2 and TFF3 can act in a compensatory 
mechanism such that TFF2 signaling promotes actin polymerization while TFF3 acts as a 
switch to downregulate polymerization and promote tight junction formation. Therefore, I 
propose to investigate whether LINGO3 downstream signaling and AJC formation is 
TFF2-dependent, future experiments should be carried out that employ biochemical and 
functional assays that can parse out: 1) if LINGO3 is directly or indirectly bound to or 
signaling through b-catenin and 2) whether LINGO3 directly or indirectly acts on different 
proteins within the AJC to promote formation (Fig 4.2). 
4.3 The role of Lingo3 on regulating Type 1 immune responses 
 Prior to the work completed for this thesis, there were no publications on LINGO3. 
There is no data on the basic biology of LINGO3 signaling or potential signaling pathways 
that may regulate Lingo3 either transcriptionally or translationally. It is known is that the 
cytoplasmic tail of LINGO3 contains both serine and tyrosine residues that kinase binding 
software predicts to be phosphorylated by kinases such as MAPK and AKT, two kinases 
that are strongly implicated in TFF2 signaling and tissue regeneration (Engevik et al., 2019; 
Orime et al., 2013). Additionally, within the locus of human Lingo3 there are 
transcriptional binding sites for the Aryl hydrocarbon receptor nuclear translocator (Arnt). 
The transcriptional binding site for Arnt is interesting given the role of AHR in regulation 
of Th17 responses and Type 1 immune responses (Yu et al., 2018). 
 Arnt forms a dimer with the Aryl hydrocarbon receptor (Ahr) within the nucleus. 
Upon dimerization, transcription occurs (Sakurai et al., 2017). AHR is a part of the basic 
helix loop helix (bHLH)/ PerARNT-Sim (PAS) superfamily of proteins (Yu et al., 2018). 
Previous work has demonstrated that upon activation of AHR by its ligand, 6- formylindolo 
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(3,2-b) carbazole (FICZ), there is downregulation of inflammatory cytokines, an increase 
in transepithelial resistance as well as localization of ZO-1, Occludin, and Claudin-1 (Yu 
et al., 2018). Furthermore, Ahr can regulate Rnf43 and Znrf3, two E3 ubiquitin ligases that 
target Wnt receptors for degradation to control ISC proliferation (Metidji et al., 2019). The 
regulatory role of Ahr on decreased expression of inflammatory cytokines, promotion of 
AJC barrier function, and ISC proliferation makes it tempting to speculate that LINGO3 is 
part of a novel regulatory signaling complex that controls cellular adhesion. 
 It is possible that Lingo3 can interact with the Ahr complex and regulate Type 17 
responses and/or repress Type 1 inflammatory cytokines. Understanding how the 
transcriptional binding sites within the Lingo3 locus represses or promotes transcription 
will be important in future work to better understand the signaling pathways that Lingo3 is 
regulated by and pathways in which Lingo3 may regulate. We do not know whether or not 
Lingo3 deficiency directly leads to enhanced Type 1 immune responses or whether 
enhanced Type 1 immune responses is secondary to the adherens junction defect observed 
within deficient mice (Fig 4.2). To begin to parse out this finding, future work will 
investigate if treatment with IFNg and TNF blocking antibodies leads to an increase in GI 
barrier function within Lingo3 KO mice . 
4.4 The implications of LINGO3 in IBD 
 Inflammatory bowel disease (IBD) constitute a spectrum of detrimental diseases of 
the GI tract that affects children, adults, third world countries, and the United States. 
Although this disease has been around since the 1930s, there have been limited efforts to 
better understand the pathobiology and factors that drive this disease (Feuerstein and 
Cheifetz, 2017). Understanding the causes and environmental triggers of IBD is essential 
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for the development of new treatments as well as curative therapies. At the onset of IBD, 
patients present with bloody stool, diarrhea, weight loss, cramping, and sometimes fever 
and fatigue (Burgmann et al., 2006; Cheifetz, 2013; Dahlhamer et al., 2016). In order to be 
diagnosed with IBD, patients need to undergo a colonoscopy, where samples of the small 
and large intestine are taken and evaluated for inflammation and tissue damage (Burgmann 
et al., 2006; Cheifetz, 2013; Dahlhamer et al., 2016). The current treatment options for IBD 
are anti-inflammatory drugs, TNF inhibitors, immune-suppressants, and sometimes 
surgery to remove the damaged portion of the intestine (Chateau and Peyrin- Biroulet, 
2019; Feuerstein and Cheifetz, 2017; Ribaldone et al., 2019; Sands et al., 2019). Although 
the innovation of TNF inhibitors for IBD has been a huge leap forward in the quality of 
life and general outcomes for patients, not all patients respond to this treatment. Therefore, 
identifying new putative therapies for refractory patients is important. 
  The TFFs have been implicated in tissue repair and regeneration during DSS- 
induced colitis (Judd et al., 2015; Kjellev et al., 2007; Kurt-Jones et al., 2007). Recent work 
has demonstrated that patients with IBD have increased serum levels of all TFFs, and 
following treatment with prednisolone, there is a reduction in TFF protein concentrations 
(Gronbaek et al., 2006). To this end, the TFFs have become in part a diagnostic marker of 
an ongoing flare during IBD. Furthermore, TFFs have been implicated as putative 
treatments for IBD. Recent work has demonstrated that TNF and NFkB can inhibit 
transcription of TFF3, which is part of why TNF inhibition has been such a promising new 
therapy for these patients (Loncar et al., 2003). To date, there have been no clinical studies 
evaluating TFF2 as a putative therapy for IBD; however, there have been a number of 
reports demonstrating that treatment with recombinant TFF2 is protective in rats and dogs 
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during experimental colitis (Tran et al., 1999). This protective role of TFF2 is in part due 
to a reduction of leukocyte recruitment in inflamed tissues (Soriano-Izquierdo et al., 2004). 
Understanding how TFFs signal and promote epithelial restitution as well as inhibition of 
apoptosis is critical for developing these proteins as putative treatments for IBD. Because 
recent work has demonstrated that TNF can inhibit TFF3 there is potential that addition of 
TFF3 to TNF blockade treatment will be synergistic, and an alternative therapy for these 
patients (Loncar et al., 2003). Based on the work presented in this thesis, it is also possible 
that a similar treatment can be designed for the use of recombinant TFF2. 
 The data presented within Chapter 2 suggests that the addition of TFF2-Fc during 
DSS-induced colitis enhances recovery of weight and drives a reduction in disease activity 
dependent upon LINGO3. This study supports a model wherein LINGO3 drives MAPK 
activation in local IECs to promote cellular proliferation. Because proliferation occurs 
downstream of MAPK signaling, future work will need to evaluate whether downstream 
of p-ERK, goblet cells are driven to proliferate, which would, in turn, lead to an increase 
in TFF2 secretion or alternatively, test if p-ERK leads to the proliferation of all intestinal 
epithelial cell types (Fig 4.3).  Interestingly, Lingo3 deficiency also affected STAT3, but 
in a TFF2-independent manner. This data further suggests that LINGO3, independent of 
TFF2, could promote reparative signaling pathways. Interestingly, in Chapter 3 we 
demonstrate no phenotype in Lingo3 deficient mice during C. rodentium infection. This 
could be because of early control of C. rodentium through enhanced IL-22 and Type 1 
cytokine production as discussed in Chapter 3, however, it could also because C. rodentium 
infection does not cause epithelial damage like that associated with IBD. There have been 
no studies implicating TFFs during C. rodentium infection. In fact, there have been no 
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studies investigating if Tff deficient mice have any defects in controlling C. rodentium 
infection or if these mice have worsened pathology during infection. To date, TFF signaling 
has only been implicated in diseases or infection models that cause severe epithelial 
damage like IBD, helminth infection, and asthma (Hung et al., 2018; Hung et al., 2019). 
Given these findings, it is not surprisingly that LINGO3, which signals in part in a TFF2 
dependent manner, has no role in a non-epithelial damaging bacterial infections. 
 To date, there have been no polymorphisms identified for Lingo3 that are associated 
with the development of IBD. Ongoing work within the Herbert laboratory is beginning to 
identify if there are polymorphisms associated with IBD risk; however, LINGO3 is the 
only LINGO family member that has not been associated with any polymorphisms, 
suggestive that defects within Lingo3 are incompatible with human life. Interestingly, using 
NCBI Geoprofile database, we have found that Lingo3 is expressed during IBD and is 
differentially expressed during a time-course of DSS-induced colitis (Fang et al., 2011; 
Moehle et al., 2006; Olsen et al., 2009; Zahn et al., 2007). To better understand if these 
trends follow the same trends as TFF expression during colitis additional research needs to 
be performed. Given these data, it is possible that manipulating LINGO3 signaling pathway 
in combination with administration of recombinant TFF2, can be a potential therapy for 
IBD patients. 
 The work in this thesis has focused on the expression pattern and signaling of 
LINGO3 in mice. Because this work has not fully evaluated LINGO3 expression within 
humans it is possible that LINGO3 expression in humans is in a different cellular 
expression pattern from mice. In mice, TFF2 has been shown to be expressed in 
macrophages in addition to epithelial cells (Hung et al., 2019). Furthermore, the Herbert 
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laboratory identified the LINGOs using a human differentiated monocyte cell line; 
therefore, it is possible that within humans, immune cell subsets in addition to epithelial 
cells can express LINGO3. Based on the data presented in Chapter 2, it is possible that 
LINGO3 dependent TFF2 signaling can promote anti-inflammatory responses such as 
induction of Tregs or secretion of IL-10 from macrophages as a potential mechanism to 
control inflammation during IBD. Therefore, future work evaluating LINGO3 expression 
patterns within humans during homeostasis as well as during IBD will be necessary. Single 
cell RNA sequencing revealed that Lingo3, albeit low expressing, was expressed on DC 
subsets as well as monocytes within humans (Villani et al., 2017). Given this data, 
understanding how LINGO3 signals within immune cells subsets and the potential role 
LINGO3 signaling has on inflammatory immune responses will be important for future 
studies. 
4.5 The implications of Lingo3 outside of the gastrointestinal tract 
 This thesis has focused on the role of LINGO3 within the GI tract. However, we 
have also noted in Chapter 2 that both in humans as well as mice express Lingo3 within 
the lung and upper airways. The general architecture and composition of the lung is 
comparable to the GI tract in that the lung contains a mucus membrane, a variety of 
epithelial and immune cell subsets, as well as tight junctions that form between epithelial 
cells (Itoh et al., 2004; Wittekindt, 2017). Furthermore, there are lung specific diseases 
such as asthma and the pulmonary phase of Nippostrongylus brasiliensis (N. brasiliensis) 
infection that are inflammatory and require tissue repair and regeneration (Hung et al., 
2018; Hung et al., 2019). 
 Asthma is a chronic inflammatory disorder that involves a number of immune cells 
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such as macrophages and T cells as well as epithelial cells (Mims, 2015). Although the 
exact cause of asthma is not known and likely pleiotropic, environmental factors such as 
air pollution and smoking as well as genetic factors have been associated with risk and 
development of asthma (Mims, 2015; Toskala and Kennedy, 2015). Type 2 inflammation 
is strongly associated to an asthmatic response. This immune infiltration within the 
bronchioles of the lung involve TH2 cells, granulocytes such as eosinophils and mast cells, 
as well as ILC2 (Huang et al., 2019; Mims, 2015; Toskala and Kennedy, 2015). 
Additionally, airway epithelial cells and alveolar macrophages infiltrate the damaged tissue 
(Mims, 2015). Similar to IBD, asthma causes epithelial hyperplasia as well as an increase 
in mucus production from goblet cells (Mims, 2015). Furthermore, TFFs, specifically 
TFF2, are known to be upregulated during asthma (Viby et al., 2015; Wills- Karp et al., 
2012). Work from the Herbert laboratory has demonstrated that TFF2 treatment can induce 
IL33, a Type 2 cytokine that is associated with inflammation during allergic response 
(Hung et al., 2018). Although TFF2 has been shown to induce IL-33 and subsequent 
inflammation, there have also been reports demonstrating treatment of recombinant TFF2 
is beneficial for controlling bronchial epithelial apoptosis and epithelial thickening during 
asthma (Royce et al., 2013). These data suggest that recombinant TFF2 could be a putative 
treatment for airway diseases (Royce et al., 2013). Interestingly, this work further 
demonstrates that TFF2 treatment does not reduce inflammation within the lung in support 
of the hypothesis that TFF2 promotes IL-33 and Type 2 inflammation (Hung et al., 2018; 
Royce et al., 2013). 
 In support of the role of TFF2 within the lung during infection, following N. 
brasiliensis infection, Tff2 mRNA expression is induced (Wills-Karp et al., 2012). 
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Nippostrongylus brasiliensis is a hookworm infection that travels to the lungs during early 
time of infection, approximately day 2, where it then migrates to the intestines (Hung et 
al., 2019; Nair and Herbert, 2016). While in the lungs, N. brasiliensis causes a massive 
amount of epithelial tissue damage leading to the induction of TFF2 (Hung et al., 2018; 
Wills-Karp et al., 2012). Furthermore, in the absence of Tff2, mice are more susceptible to 
lung damage and have increased amount of hemorrhage at day 1 post infection as compared 
to Tff2 deficient mice at steady state or WT mice during infection (Wills-Karp et al., 2012). 
Additionally, post N. brasiliensis infection, Tff2 deficient mice had a reduction in lung 
collagen, suggestive of a lack a lung repair (Wills-Karp et al., 2012). Given these data and 
the role of TFF2 during asthma infection, it suggests that the TFF2 signaling pathway is 
required for lung repair in two lung injury models. Because of the expression of LINGO3 
within the lung and the implications LINGO3 has on TFF2 mediated signaling during DSS-
induced colitis, it is possible that LINGO3 is also necessary during repair of lung injury. 
 Preliminary data demonstrates that similar to the GI tract, there is increased lung 
permeability within Lingo3 deficient mice at the steady-state (Fig 4.4). These data suggest 
that there could be an apical junction defect within different epithelial cell populations of 
the lung. Interestingly, during asthma, IL-13, a known Type 2 cytokine has been shown to 
drive changes within claudin expression as well as enhanced permeability (Schmidt et al., 
2019). Given these data it is possible that defects within tight junctions can lead to 
worsened severity of asthma infection. Furthermore, mice infected with N. brasiliensis 
demonstrated enhanced endotoxin levels, demonstrating that 
N. brasiliensis infection disrupts tight junctions and leads to epithelial denudation (Farid 
et al., 2008). Although LINGO3 has not yet been studied in disease models of asthma, there 
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has been datasets that have identified differential expression of Lingo3 during asthma (Lu 
et al., 2007; Subrata et al., 2009) (https://www.ncbi.nlm.nih.gov/geoprofiles/8523063). 
However, based on the available data there is no consistent trends of Lingo3 expression 
being dysregulated during asthma infection. Therefore, future work will need to be 
performed to understand the expression of Lingo3 during various periods and onsets of 
asthmatic disease. Understanding the role of LINGO3 signaling within the lung will be 
important to elucidate novel repair mechanisms during lung injury. Future work will focus 
on the implications of Lingo3 deficiency on asthma and whether or not LINGO3 can 
regulate Type 2 immune responses in a similar fashion to TFF2 (Hung et al., 2018; Hung 
et al., 2019; Wills-Karp et al., 2012). 
Conclusions 
 Taken together, the work presented in this thesis has identified LINGO3, a novel 
leucine rich repeat transmembrane receptor, as an important protein expressed within 
mucosal sites that functions to control tight junctions and tissue repair during DSS- induced 
colitis. Given the expression patterns of LINGO3 in human gastrointestinal tissue it is 
possible that LINGO3 is expressed on ISCs as well as other cell subsets 
outside of intestinal epithelial cells. Additionally, this thesis provides evidence that 
LINGO3 is an important reparative protein that is involved within the TFF2 signaling 
pathway but does not directly interact with TFF2. This leads to an open-ended question of 
what LINGO3 is a receptor for and whether or not it forms a complex with other proteins 
similar to what has been shown with LINGO1 and LINGO2. This work has laid the 
foundation for future studies involving LINGO3. Understanding how LINGO3 signals, 
other putative binding proteins for LINGO3, as well as if LINGO3 directly functions within 
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the ISC niche or on the AJC will be important for elucidating the mechanisms that LINGO3 
utilizes to promote tissue repair during human diseases such as IBD and asthma. 
Methods 
 FITC-Dextran assay. WT and Lingo3 KO mice were fasted for 16 hours prior to 
4 kDa FITC-Dextran (Sigma, FD4) administration. Mice were anesthetized using 
isoflurane prior to intratracheal challenge. For intratracheal challenge, mice are placed on 
a plexiglass inclined plane and hung by the incisors. The tongue is gently held with forceps 
and 50 µL of 4 kDa FITC-Dextran was placed on the back of the tongue. The mouth was 
then closed for aspiration of the droplet. Mice were euthanized following 4 hours of 
administration. Blood was collected from the heart using a cardiac puncture and 
centrifuged at 10,000 RPM for 10 minutes at 4C to isolate sera. FITC-Dextran assay was 
performed in the same manner as described in the methods section of Chapter 2: Evaluation 
of intestinal permeability. 
 Geo-Profile data search: The NCBI website geo-profile 
(https://www.ncbi.nlm.nih.gov/geoprofiles/) was used to search datasets on the 
expression of Lingo3 during IBD and asthma. The terms used for these searches were as 
follows “Lingo3 and colitis” and “Lingo3 and asthma”. ID numbers were referenced for 





Fig. 4.1 LINGO3 may have a functional role in the intestinal stem cell niche.  
1) LINGO3 may be expressed on Lgr5+ intestinal stem cell, and downstream signaling 
leads to cellular differentiation, repopulating the intestinal villus with mature epithelial 
cells. 2) Alternatively, LINGO3 may be expressed on either a transit amplifying cell or 
paneth cell and downstream signaling leads to the secretion of WNT ligands which can 




Figure 4.2 LINGO3 may have a functional role within the apical junction complex. 1) 
LINGO3 may indirectly regulate the formation or protein expression of tight junction 
proteins (claudins, occludens, or ZO proteins). 2) LINGO3 may indirectly regulate the 
protein expression of junctional adhesion molecules (JAMs). 3) LINGO3 regulates the 
formation of the adherens junction complex either indirectly through downstream signaling 




 Figure 4.3 Potential functional role of a LINGO3-TFF2 axis in inflammatory 
bowel disease. During DSS-induced injury, goblet cells secrete TFF2. TFF2 can  indirectly 
signal through LINGO3, expressed on enterocytes, leading to downstream signaling of 
MAPK, specifically activation of ERK via phosphorylation. P-ERK can lead to cellular 
proliferation either 1) directly on goblet cells leading to further TFF2 secretion or 2) 






























Fig 4.4 Lingo 3 deficient mice have a lung permeability defect. 
(a) FITC-Dextran concentration within sera following intratracheal 
administration of 44mg/100g of 4kDA of FITC-Dextran. N= 6 cohoused mice/genotype
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